| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | TRAF7 TRIM45 ZNF276 THRB ZNF330 ESR1 ESR2 MBD1 NFX1 MYRIP NFXL1 ZMYM2 ADAM30 NR1H2 GRIN2B ZCCHC7 HNF4A ZMYM3 | 5.25e-08 | 891 | 88 | 18 | GO:0008270 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 6.15e-07 | 16 | 88 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 STAB2 HMCN1 SUSD1 LPL LRP1 LRP2 DGKA LTBP3 SMOC1 ITGB1 NOTCH2 NOTCH3 RASGRP2 STAB1 | 8.84e-07 | 749 | 88 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.80e-06 | 188 | 88 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.99e-06 | 21 | 88 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | transition metal ion binding | TRAF7 TRIM45 ZNF276 THRB ZNF330 ESR1 ESR2 MBD1 NFX1 MYRIP NFXL1 ZMYM2 ADAM30 NR1H2 GRIN2B ZCCHC7 HNF4A ZMYM3 | 3.53e-06 | 1189 | 88 | 18 | GO:0046914 |
| GeneOntologyMolecularFunction | scavenger receptor activity | 5.72e-06 | 27 | 88 | 4 | GO:0005044 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 6.69e-06 | 60 | 88 | 5 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 7.26e-06 | 61 | 88 | 5 | GO:0098531 | |
| GeneOntologyMolecularFunction | integrin binding | 1.23e-05 | 175 | 88 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.76e-05 | 73 | 88 | 5 | GO:0050840 | |
| GeneOntologyMolecularFunction | alpha-L-arabinofuranosidase activity | 1.92e-05 | 2 | 88 | 2 | GO:0046556 | |
| GeneOntologyMolecularFunction | collagen binding | 2.92e-05 | 81 | 88 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.68e-05 | 85 | 88 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 8.99e-05 | 323 | 88 | 8 | GO:1901681 | |
| GeneOntologyMolecularFunction | hormone binding | 9.24e-05 | 103 | 88 | 5 | GO:0042562 | |
| GeneOntologyMolecularFunction | chromatin binding | EBF2 ZNF276 THRB EGFR ESR1 ESR2 MBD1 NR1H2 EZH2 HNF4A SFMBT2 MSL2 | 9.41e-05 | 739 | 88 | 12 | GO:0003682 |
| GeneOntologyMolecularFunction | nuclear estrogen receptor activity | 1.15e-04 | 4 | 88 | 2 | GO:0030284 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 1.33e-04 | 59 | 88 | 4 | GO:0001222 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.82e-04 | 268 | 88 | 7 | GO:0005539 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.90e-04 | 120 | 88 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 2.78e-04 | 29 | 88 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 3.02e-04 | 599 | 88 | 10 | GO:0050839 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.87e-04 | 140 | 88 | 5 | GO:0001221 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | EBF2 ZNF211 THRB ZNF391 ZNF678 EBF3 ESR1 ESR2 NFX1 NFXL1 ZBTB47 NR1H2 EBF1 ZNF229 HNF4A NOTCH2 | 4.05e-04 | 1412 | 88 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 4.89e-04 | 35 | 88 | 3 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 4.89e-04 | 35 | 88 | 3 | GO:0071814 | |
| GeneOntologyMolecularFunction | growth factor binding | 6.35e-04 | 156 | 88 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 6.74e-04 | 39 | 88 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 8.04e-04 | 560 | 88 | 9 | GO:0001228 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 8.63e-04 | 167 | 88 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 8.67e-04 | 566 | 88 | 9 | GO:0001216 | |
| GeneOntologyMolecularFunction | estrogen response element binding | 1.03e-03 | 11 | 88 | 2 | GO:0034056 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.48e-03 | 51 | 88 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | heparin binding | 1.60e-03 | 192 | 88 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | EBF2 ZNF211 THRB ZNF391 ZNF678 EBF3 ESR1 ESR2 NFX1 NFXL1 NR1H2 EBF1 ZNF229 EZH2 HNF4A | 1.68e-03 | 1459 | 88 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.92e-03 | 200 | 88 | 5 | GO:0008237 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 2.81e-03 | 18 | 88 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 3.46e-03 | 20 | 88 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | EBF2 ZNF211 THRB ZNF678 EBF3 ESR1 ESR2 NR1H2 EBF1 ZNF229 EZH2 HNF4A NOTCH2 | 3.67e-03 | 1271 | 88 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | coreceptor activity | 3.96e-03 | 72 | 88 | 3 | GO:0015026 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 5.39e-03 | 25 | 88 | 2 | GO:0003707 | |
| GeneOntologyMolecularFunction | structural molecule activity | 5.77e-03 | 891 | 88 | 10 | GO:0005198 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 5.87e-03 | 163 | 88 | 4 | GO:0031072 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 5.89e-03 | 83 | 88 | 3 | GO:1990841 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 7.45e-06 | 238 | 87 | 8 | GO:0050954 | |
| GeneOntologyBiologicalProcess | vagina development | 1.17e-05 | 11 | 87 | 3 | GO:0060068 | |
| GeneOntologyBiologicalProcess | gliogenesis | 1.48e-05 | 435 | 87 | 10 | GO:0042063 | |
| GeneOntologyBiologicalProcess | arabinose metabolic process | 1.76e-05 | 2 | 87 | 2 | GO:0019566 | |
| GeneOntologyBiologicalProcess | vibrational conductance of sound to the inner ear | 1.76e-05 | 2 | 87 | 2 | GO:0055127 | |
| GeneOntologyBiologicalProcess | L-arabinose metabolic process | 1.76e-05 | 2 | 87 | 2 | GO:0046373 | |
| GeneOntologyBiologicalProcess | sensory perception of sound | 2.06e-05 | 198 | 87 | 7 | GO:0007605 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 2.66e-05 | 83 | 87 | 5 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 2.82e-05 | 84 | 87 | 5 | GO:0061614 | |
| GeneOntologyBiologicalProcess | positive regulation of chemokine (C-X-C motif) ligand 2 production | 3.18e-05 | 15 | 87 | 3 | GO:2000343 | |
| GeneOntologyBiologicalProcess | blood vessel development | HSPG2 ERBB2 STAB2 CCN1 DCTN5 LRP1 LRP2 PRKD1 BMPER ADAM12 ITGB1 NOTCH2 NOTCH3 STAB1 | 3.23e-05 | 929 | 87 | 14 | GO:0001568 |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 3.56e-05 | 385 | 87 | 9 | GO:0070372 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | HSPG2 ERBB2 STAB2 CCN1 LRP1 LRP2 PRKD1 BMPER ADAM12 ITGB1 NOTCH2 NOTCH3 STAB1 | 3.66e-05 | 817 | 87 | 13 | GO:0048514 |
| GeneOntologyBiologicalProcess | vasculature development | HSPG2 ERBB2 STAB2 CCN1 DCTN5 LRP1 LRP2 PRKD1 BMPER ADAM12 ITGB1 NOTCH2 NOTCH3 STAB1 | 5.11e-05 | 969 | 87 | 14 | GO:0001944 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | ERBB2 VTN CCN1 CILP EGFR ADAM9 LRP1 LRP2 PRKD1 LTBP3 BMPER ITGB1 NOTCH2 | 5.49e-05 | 850 | 87 | 13 | GO:0071363 |
| GeneOntologyBiologicalProcess | glial cell differentiation | 6.34e-05 | 321 | 87 | 8 | GO:0010001 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | HSPG2 ERBB2 STAB2 CCN1 EGFR ESR1 LRP1 LRP2 PRKD1 BMPER ADAM12 ITGB1 NOTCH2 NOTCH3 STAB1 | 6.67e-05 | 1125 | 87 | 15 | GO:0035239 |
| GeneOntologyBiologicalProcess | tube development | HSPG2 ERBB2 STAB2 THRB CCN1 EGFR ESR1 LRP1 LRP2 PRKD1 LTBP3 BMPER ADAM12 ITGB1 NOTCH2 NOTCH3 STAB1 | 6.69e-05 | 1402 | 87 | 17 | GO:0035295 |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 6.72e-05 | 418 | 87 | 9 | GO:0070371 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 7.52e-05 | 103 | 87 | 5 | GO:2000628 | |
| GeneOntologyBiologicalProcess | female genitalia development | 7.85e-05 | 20 | 87 | 3 | GO:0030540 | |
| GeneOntologyBiologicalProcess | response to growth factor | ERBB2 VTN CCN1 CILP EGFR ADAM9 LRP1 LRP2 PRKD1 LTBP3 BMPER ITGB1 NOTCH2 | 8.08e-05 | 883 | 87 | 13 | GO:0070848 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.08e-04 | 445 | 87 | 9 | GO:0141091 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | ERBB2 VTN CCN1 CILP EGFR ADAM9 ESR1 ESR2 LRP1 LRP2 PRKD1 LTBP3 BMPER ITGB1 NOTCH2 | 1.20e-04 | 1186 | 87 | 15 | GO:0007167 |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 1.28e-04 | 61 | 87 | 4 | GO:1902895 | |
| GeneOntologyBiologicalProcess | chemokine (C-X-C motif) ligand 2 production | 1.38e-04 | 24 | 87 | 3 | GO:0072567 | |
| GeneOntologyBiologicalProcess | regulation of chemokine (C-X-C motif) ligand 2 production | 1.38e-04 | 24 | 87 | 3 | GO:2000341 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | 1.44e-04 | 571 | 87 | 10 | GO:0043410 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 1.49e-04 | 119 | 87 | 5 | GO:0010586 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | TRAF7 ERBB2 CCN1 EGFR ADAM9 ESR1 ESR2 LRP1 GRIN2B BMPER EZH2 NOTCH2 | 1.56e-04 | 815 | 87 | 12 | GO:0043408 |
| GeneOntologyBiologicalProcess | regulation of protein localization | TRAF7 ERBB2 SLC8B1 EGFR ADAM9 LRP1 MYRIP LRP2 NR1H2 PRKD1 BMPER HNF4A ITGB1 ADAM22 | 1.73e-04 | 1087 | 87 | 14 | GO:0032880 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.74e-04 | 5 | 87 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 1.74e-04 | 5 | 87 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | angiogenesis | HSPG2 ERBB2 STAB2 CCN1 PRKD1 BMPER ADAM12 ITGB1 NOTCH2 NOTCH3 STAB1 | 1.88e-04 | 708 | 87 | 11 | GO:0001525 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | 1.91e-04 | 591 | 87 | 10 | GO:1903829 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.92e-04 | 377 | 87 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.96e-04 | 378 | 87 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.97e-04 | 482 | 87 | 9 | GO:0007178 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.99e-04 | 379 | 87 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | axon guidance | 2.03e-04 | 285 | 87 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.08e-04 | 286 | 87 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | response to estradiol | 2.09e-04 | 128 | 87 | 5 | GO:0032355 | |
| GeneOntologyBiologicalProcess | positive regulation of bone resorption | 2.20e-04 | 28 | 87 | 3 | GO:0045780 | |
| GeneOntologyBiologicalProcess | sensory organ development | KMT2C THRB EGFR OTOGL GRXCR1 GRIN2B BMPER SMOC1 USH2A NOTCH2 OTOG | 2.45e-04 | 730 | 87 | 11 | GO:0007423 |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 2.57e-04 | 73 | 87 | 4 | GO:2000630 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 2.59e-04 | 134 | 87 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 2.61e-04 | 6 | 87 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 2.61e-04 | 6 | 87 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | response to trichostatin A | 2.61e-04 | 6 | 87 | 2 | GO:0035983 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | EBF2 ERBB2 VTN CCN1 EGFR ADAM9 ESR1 ESR2 LRP1 NR1H2 PRKD1 GRIN2B EZH2 ITGB1 NOTCH2 RASGRP2 | 2.84e-04 | 1430 | 87 | 16 | GO:0044093 |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 3.01e-04 | 403 | 87 | 8 | GO:1904951 | |
| GeneOntologyBiologicalProcess | circulatory system development | HSPG2 ERBB2 STAB2 CCN1 EGFR DCTN5 MBD1 LRP1 LRP2 PRKD1 BMPER ADAM12 ITGB1 NOTCH2 NOTCH3 STAB1 | 3.12e-04 | 1442 | 87 | 16 | GO:0072359 |
| GeneOntologyBiologicalProcess | animal organ regeneration | 3.49e-04 | 79 | 87 | 4 | GO:0031100 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 3.49e-04 | 412 | 87 | 8 | GO:0090287 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 3.64e-04 | 7 | 87 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 3.64e-04 | 7 | 87 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 3.64e-04 | 7 | 87 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | liver regeneration | 3.95e-04 | 34 | 87 | 3 | GO:0097421 | |
| GeneOntologyBiologicalProcess | amide transport | 3.97e-04 | 420 | 87 | 8 | GO:0042886 | |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | 4.02e-04 | 319 | 87 | 7 | GO:0051222 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | HSPG2 KMT2C ERBB2 THRB CCN1 EGFR ESR1 LRP2 PRKD1 LTBP3 EZH2 ITGB1 NOTCH2 NOTCH3 | 4.35e-04 | 1190 | 87 | 14 | GO:0008284 |
| GeneOntologyBiologicalProcess | Sertoli cell proliferation | 4.84e-04 | 8 | 87 | 2 | GO:0060011 | |
| GeneOntologyBiologicalProcess | ERBB2-EGFR signaling pathway | 4.84e-04 | 8 | 87 | 2 | GO:0038134 | |
| GeneOntologyBiologicalProcess | cellular response to estradiol stimulus | 5.08e-04 | 37 | 87 | 3 | GO:0071392 | |
| GeneOntologyBiologicalProcess | MAPK cascade | TRAF7 ERBB2 CCN1 EGFR ADAM9 ESR1 ESR2 LRP1 GRIN2B BMPER EZH2 NOTCH2 | 5.17e-04 | 930 | 87 | 12 | GO:0000165 |
| GeneOntologyBiologicalProcess | acylglycerol metabolic process | 5.21e-04 | 156 | 87 | 5 | GO:0006639 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | TRAF7 ERBB2 SLC8B1 EGFR ADAM9 LRP1 MYRIP LRP2 NR1H2 PRKD1 BMPER HNF4A ITGB1 ADAM22 | 5.22e-04 | 1212 | 87 | 14 | GO:0060341 |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 5.36e-04 | 240 | 87 | 6 | GO:0070374 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | 5.39e-04 | 674 | 87 | 10 | GO:0070201 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 5.50e-04 | 38 | 87 | 3 | GO:0048384 | |
| GeneOntologyBiologicalProcess | neutral lipid metabolic process | 5.52e-04 | 158 | 87 | 5 | GO:0006638 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 5.58e-04 | 337 | 87 | 7 | GO:0006898 | |
| GeneOntologyBiologicalProcess | regulation of protein transport | 5.88e-04 | 560 | 87 | 9 | GO:0051223 | |
| GeneOntologyBiologicalProcess | subtelomeric heterochromatin formation | 6.21e-04 | 9 | 87 | 2 | GO:0031509 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | EBF2 KMT2C THRB CCN1 EGFR EBF3 ESR1 ESR2 NR1H2 PRKD1 EBF1 ZNF229 HNF4A NOTCH2 NOTCH3 | 6.59e-04 | 1390 | 87 | 15 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of lipase activity | 6.88e-04 | 41 | 87 | 3 | GO:0060191 | |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 6.97e-04 | 350 | 87 | 7 | GO:0050708 | |
| GeneOntologyBiologicalProcess | ovulation cycle | 7.02e-04 | 95 | 87 | 4 | GO:0042698 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 7.30e-04 | 96 | 87 | 4 | GO:0060113 | |
| GeneOntologyBiologicalProcess | peptide transport | 7.58e-04 | 355 | 87 | 7 | GO:0015833 | |
| GeneOntologyBiologicalProcess | male gonad development | 7.89e-04 | 171 | 87 | 5 | GO:0008584 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 7.92e-04 | 43 | 87 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 8.10e-04 | 172 | 87 | 5 | GO:0046546 | |
| GeneOntologyBiologicalProcess | rhythmic process | 8.22e-04 | 360 | 87 | 7 | GO:0048511 | |
| GeneOntologyBiologicalProcess | neuron projection development | HSPG2 ERBB2 EGFR OTOGL LRP1 LRP2 LAMA2 GRXCR1 PRKD1 EZH2 ITGB1 NOTCH2 NOTCH3 OTOG | 9.27e-04 | 1285 | 87 | 14 | GO:0031175 |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 9.44e-04 | 11 | 87 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | mitotic spindle midzone assembly | 9.44e-04 | 11 | 87 | 2 | GO:0051256 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 9.85e-04 | 104 | 87 | 4 | GO:0042490 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell proliferation | 9.91e-04 | 270 | 87 | 6 | GO:0050679 | |
| GeneOntologyBiologicalProcess | neuron development | HSPG2 ERBB2 THRB EGFR OTOGL LRP1 LRP2 LAMA2 GRXCR1 PRKD1 EZH2 ITGB1 NOTCH2 NOTCH3 OTOG | 1.11e-03 | 1463 | 87 | 15 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 1.13e-03 | 12 | 87 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | mitotic spindle elongation | 1.13e-03 | 12 | 87 | 2 | GO:0000022 | |
| GeneOntologyBiologicalProcess | regulation of peptide hormone secretion | 1.13e-03 | 277 | 87 | 6 | GO:0090276 | |
| GeneOntologyBiologicalProcess | regulation of peptide transport | 1.24e-03 | 282 | 87 | 6 | GO:0090087 | |
| GeneOntologyBiologicalProcess | regulation of peptide secretion | 1.24e-03 | 282 | 87 | 6 | GO:0002791 | |
| GeneOntologyBiologicalProcess | heart development | 1.31e-03 | 757 | 87 | 10 | GO:0007507 | |
| GeneOntologyBiologicalProcess | constitutive heterochromatin formation | 1.33e-03 | 13 | 87 | 2 | GO:0140719 | |
| GeneOntologyBiologicalProcess | pentose metabolic process | 1.33e-03 | 13 | 87 | 2 | GO:0019321 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 1.38e-03 | 194 | 87 | 5 | GO:0050714 | |
| GeneOntologyBiologicalProcess | inflammatory response | TRIM45 HSPG2 EGFR ESR1 LPL NFX1 LRP1 PRKD1 EZH2 ITGB1 NOTCH2 STAB1 | 1.40e-03 | 1043 | 87 | 12 | GO:0006954 |
| GeneOntologyCellularComponent | basement membrane | 4.24e-08 | 122 | 87 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 FRAS1 VTN HMCN1 CCN1 CILP OTOGL LRRTM4 LAMA2 LTBP3 BMPER SMOC1 USH2A ITGB1 OTOG | 7.81e-08 | 656 | 87 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 FRAS1 VTN HMCN1 CCN1 CILP OTOGL LRRTM4 LAMA2 LTBP3 BMPER SMOC1 USH2A ITGB1 OTOG | 8.12e-08 | 658 | 87 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 FRAS1 VTN HMCN1 CCN1 CILP LAMA2 LTBP3 BMPER SMOC1 USH2A ITGB1 | 1.96e-06 | 530 | 87 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | ruffle membrane | 8.85e-05 | 108 | 87 | 5 | GO:0032587 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.46e-04 | 210 | 87 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | membrane attack complex | 3.55e-04 | 7 | 87 | 2 | GO:0005579 | |
| GeneOntologyCellularComponent | receptor complex | 6.95e-04 | 581 | 87 | 9 | GO:0043235 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 1.55e-03 | 785 | 87 | 10 | GO:0098797 | |
| GeneOntologyCellularComponent | ruffle | 1.70e-03 | 206 | 87 | 5 | GO:0001726 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.91e-03 | 59 | 87 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.93e-03 | 212 | 87 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | cell surface | STAB2 EGFR ADAM9 LPL LRP1 LRP2 ADAM30 ADAM2 GRIN2B ITGB1 NOTCH2 NOTCH3 | 2.13e-03 | 1111 | 87 | 12 | GO:0009986 |
| GeneOntologyCellularComponent | cell projection membrane | 2.14e-03 | 431 | 87 | 7 | GO:0031253 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.24e-03 | 17 | 87 | 2 | GO:0098637 | |
| MousePheno | perinatal lethality | HSPG2 KMT2C ERBB2 CCN1 EGFR EBF3 LPL LRP1 LRP2 LAMA2 PRKD1 GRIN2B BMPER SMOC1 EZH2 ITGB1 ADAM22 DISP1 NOTCH2 | 2.26e-06 | 1130 | 71 | 19 | MP:0002081 |
| MousePheno | abnormal skeleton development | EBF2 HSPG2 THRB EGFR ESR1 ESR2 LTBP3 EBF1 BMPER DISP1 NOTCH2 NOTCH3 | 2.28e-06 | 447 | 71 | 12 | MP:0002113 |
| MousePheno | abnormal compact bone morphology | 2.46e-06 | 172 | 71 | 8 | MP:0003797 | |
| MousePheno | abnormal osteoblast cell number | 2.47e-06 | 77 | 71 | 6 | MP:0004987 | |
| MousePheno | increased osteoclast cell number | 2.47e-06 | 77 | 71 | 6 | MP:0004984 | |
| MousePheno | abnormal compact bone thickness | 2.72e-06 | 122 | 71 | 7 | MP:0000134 | |
| MousePheno | abnormal bone mineralization | 3.59e-06 | 181 | 71 | 8 | MP:0002896 | |
| MousePheno | abnormal forebrain morphology | EBF2 TRIM45 HSPG2 THRB EGFR EBF3 ESR1 ESR2 MBD1 LRRTM4 LRP1 LRP2 ZMYM2 KIF4A KIF4B EBF1 GRIN2B DISP1 | 4.57e-06 | 1072 | 71 | 18 | MP:0000783 |
| MousePheno | abnormal hindlimb morphology | EBF2 HSPG2 FRAS1 THRB EGFR ESR1 ESR2 TMEM63B NFXL1 SMOC1 EZH2 PLEKHM1 NOTCH2 | 5.56e-06 | 576 | 71 | 13 | MP:0000556 |
| MousePheno | abnormal osteoblast morphology | 5.87e-06 | 137 | 71 | 7 | MP:0004986 | |
| MousePheno | decreased length of long bones | EBF2 HSPG2 THRB ESR1 ESR2 TMEM63B NFXL1 LTBP3 SMOC1 PLEKHM1 NOTCH2 | 6.21e-06 | 409 | 71 | 11 | MP:0004686 |
| MousePheno | abnormal long bone morphology | EBF2 HSPG2 THRB ESR1 ESR2 TMEM63B NFXL1 LTBP3 EBF1 BMPER SMOC1 EZH2 PLEKHM1 NOTCH2 | 6.21e-06 | 676 | 71 | 14 | MP:0003723 |
| MousePheno | abnormal cartilage morphology | 7.08e-06 | 336 | 71 | 10 | MP:0000163 | |
| MousePheno | abnormal somatic sensory system morphology | EBF2 ERBB2 THRB EGFR EBF3 ESR2 TMEM63B LAMA2 NR1H2 GRXCR1 SMOC1 USH2A DISP1 OTOG | 9.56e-06 | 702 | 71 | 14 | MP:0000959 |
| MousePheno | abnormal somatic nervous system morphology | EBF2 HSPG2 ERBB2 THRB HMCN1 EGFR EBF3 ESR2 TMEM63B LAMA2 NR1H2 GRXCR1 SMOC1 USH2A DISP1 PLEKHM1 OTOG | 1.06e-05 | 1025 | 71 | 17 | MP:0002752 |
| MousePheno | abnormal limb morphology | EBF2 HSPG2 FRAS1 THRB EGFR ESR1 ESR2 TMEM63B LRP1 NFXL1 BMPER SMOC1 EZH2 ITGB1 DISP1 PLEKHM1 NOTCH2 | 1.10e-05 | 1028 | 71 | 17 | MP:0002109 |
| MousePheno | perinatal lethality, complete penetrance | KMT2C ERBB2 CCN1 EGFR EBF3 LPL LRP1 LRP2 GRIN2B BMPER SMOC1 EZH2 DISP1 NOTCH2 | 1.12e-05 | 712 | 71 | 14 | MP:0011089 |
| MousePheno | abnormal skeleton physiology | EBF2 HSPG2 THRB ESR1 ESR2 LAMA2 NR1H2 LTBP3 EBF1 EZH2 PLEKHM1 NOTCH2 NOTCH3 | 1.51e-05 | 632 | 71 | 13 | MP:0001533 |
| MousePheno | abnormal mechanoreceptor morphology | 2.14e-05 | 231 | 71 | 8 | MP:0000972 | |
| MousePheno | abnormal inner ear morphology | 2.15e-05 | 303 | 71 | 9 | MP:0000026 | |
| MousePheno | abnormal ear morphology | HSPG2 THRB EGFR ESR2 TMEM63B LRP2 LAMA2 GRXCR1 BMPER USH2A OTOG | 2.28e-05 | 470 | 71 | 11 | MP:0002102 |
| MousePheno | abnormal cochlear labyrinth morphology | 2.42e-05 | 235 | 71 | 8 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 2.42e-05 | 235 | 71 | 8 | MP:0003169 | |
| MousePheno | abnormal axial skeleton morphology | TRIM45 HSPG2 FRAS1 THRB EGFR DCTN5 ESR1 MBD1 LRP2 LAMA2 LTBP3 BMPER SMOC1 EZH2 ITGB1 DISP1 PLEKHM1 NOTCH2 NOTCH3 SSUH2 | 2.48e-05 | 1458 | 71 | 20 | MP:0002114 |
| MousePheno | abnormal limb long bone morphology | EBF2 HSPG2 THRB ESR1 ESR2 TMEM63B NFXL1 BMPER SMOC1 EZH2 PLEKHM1 NOTCH2 | 2.58e-05 | 568 | 71 | 12 | MP:0011504 |
| MousePheno | abnormal long bone epiphyseal plate morphology | 2.59e-05 | 172 | 71 | 7 | MP:0003055 | |
| MousePheno | abnormal bone remodeling | 3.23e-05 | 178 | 71 | 7 | MP:0002998 | |
| MousePheno | abnormal appendicular skeleton morphology | EBF2 HSPG2 FRAS1 THRB ESR1 ESR2 TMEM63B NFXL1 LTBP3 EBF1 BMPER SMOC1 EZH2 PLEKHM1 NOTCH2 | 3.48e-05 | 896 | 71 | 15 | MP:0009250 |
| MousePheno | abnormal Schwann cell morphology | 3.56e-05 | 37 | 71 | 4 | MP:0001106 | |
| MousePheno | abnormal PNS glial cell morphology | 3.56e-05 | 37 | 71 | 4 | MP:0001105 | |
| MousePheno | abnormal cochlea morphology | 3.56e-05 | 248 | 71 | 8 | MP:0000031 | |
| MousePheno | abnormal limb bone morphology | EBF2 HSPG2 THRB ESR1 ESR2 TMEM63B NFXL1 BMPER SMOC1 EZH2 PLEKHM1 NOTCH2 | 3.56e-05 | 587 | 71 | 12 | MP:0002115 |
| MousePheno | abnormal osteoclast morphology | 3.85e-05 | 183 | 71 | 7 | MP:0004982 | |
| MousePheno | increased osteoblast cell number | 3.96e-05 | 38 | 71 | 4 | MP:0004988 | |
| MousePheno | limbs/digits/tail phenotype | EBF2 HSPG2 FRAS1 THRB EGFR ESR1 ESR2 TMEM63B LRP1 LRP2 NFXL1 BMPER SMOC1 EZH2 ITGB1 DISP1 PLEKHM1 NOTCH2 | 4.07e-05 | 1258 | 71 | 18 | MP:0005371 |
| MousePheno | abnormal epiphyseal plate morphology | 4.13e-05 | 185 | 71 | 7 | MP:0006395 | |
| MousePheno | abnormal osteoclast cell number | 4.61e-05 | 128 | 71 | 6 | MP:0004983 | |
| MousePheno | abnormal membranous labyrinth morphology | 5.25e-05 | 262 | 71 | 8 | MP:0000035 | |
| MousePheno | decreased compact bone thickness | 6.26e-05 | 83 | 71 | 5 | MP:0000135 | |
| MousePheno | short tibia | 7.19e-05 | 274 | 71 | 8 | MP:0002764 | |
| MousePheno | increased dendritic spine number | 7.61e-05 | 3 | 71 | 2 | MP:0021019 | |
| MousePheno | microphthalmia | 8.57e-05 | 362 | 71 | 9 | MP:0001297 | |
| MousePheno | abnormal blood vessel morphology | EBF2 TRIM45 HSPG2 ERBB2 FRAS1 CCN1 EGFR ADAM9 ESR2 LPL LRP2 TRMT1 BMPER SMOC1 HNF4A ITGB1 DISP1 NOTCH2 NOTCH3 | 9.64e-05 | 1472 | 71 | 19 | MP:0001614 |
| MousePheno | abnormal sensory neuron innervation pattern | 1.02e-04 | 92 | 71 | 5 | MP:0000968 | |
| MousePheno | abnormal hair cell morphology | 1.04e-04 | 214 | 71 | 7 | MP:0000045 | |
| MousePheno | abnormal femur morphology | 1.04e-04 | 214 | 71 | 7 | MP:0000559 | |
| MousePheno | abnormal trabecular bone morphology | 1.04e-04 | 289 | 71 | 8 | MP:0000130 | |
| MousePheno | abnormal muscle morphology | HSPG2 ERBB2 EGFR ESR1 ESR2 LPL LRP1 LRP2 LAMA2 EZH2 ADAM12 ITGB1 DISP1 NOTCH2 NOTCH3 SSUH2 | 1.06e-04 | 1106 | 71 | 16 | MP:0002108 |
| MousePheno | abnormal hindlimb stylopod morphology | 1.07e-04 | 215 | 71 | 7 | MP:0003856 | |
| MousePheno | abnormal eye size | 1.12e-04 | 375 | 71 | 9 | MP:0002697 | |
| MousePheno | decreased bone mineralization | 1.28e-04 | 51 | 71 | 4 | MP:0020137 | |
| MousePheno | abnormal sensory neuron morphology | 1.30e-04 | 473 | 71 | 10 | MP:0000965 | |
| MousePheno | abnormal vertebral column morphology | TRIM45 HSPG2 FRAS1 ESR1 MBD1 LAMA2 LTBP3 BMPER EZH2 ITGB1 PLEKHM1 NOTCH2 NOTCH3 | 1.44e-04 | 787 | 71 | 13 | MP:0004703 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | KMT2C ERBB2 FRAS1 CCN1 EGFR EBF3 LPL LRP1 LRP2 GRIN2B BMPER SMOC1 EZH2 ITGB1 ADAM22 DISP1 NOTCH2 | 1.58e-04 | 1269 | 71 | 17 | MP:0011111 |
| MousePheno | abnormal bone ossification | 1.66e-04 | 395 | 71 | 9 | MP:0008271 | |
| MousePheno | increased macrophage cell number | 1.70e-04 | 162 | 71 | 6 | MP:0005425 | |
| MousePheno | increased or absent threshold for auditory brainstem response | 1.90e-04 | 236 | 71 | 7 | MP:0011967 | |
| MousePheno | abnormal cranium morphology | HSPG2 FRAS1 THRB EGFR DCTN5 LRP2 LAMA2 LTBP3 BMPER SMOC1 ITGB1 DISP1 SSUH2 | 1.99e-04 | 813 | 71 | 13 | MP:0000438 |
| MousePheno | abnormal femur compact bone thickness | 2.07e-04 | 23 | 71 | 3 | MP:0013622 | |
| MousePheno | abnormal digit development | 2.07e-04 | 23 | 71 | 3 | MP:0006280 | |
| MousePheno | embryonic lethality, incomplete penetrance | 2.19e-04 | 410 | 71 | 9 | MP:0011102 | |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | 2.19e-04 | 410 | 71 | 9 | MP:0031660 | |
| MousePheno | abnormal skeletal muscle morphology | 2.32e-04 | 508 | 71 | 10 | MP:0000759 | |
| MousePheno | abnormal craniofacial bone morphology | HSPG2 FRAS1 THRB EGFR DCTN5 LRP2 LAMA2 LTBP3 BMPER SMOC1 ITGB1 DISP1 SSUH2 | 2.35e-04 | 827 | 71 | 13 | MP:0002116 |
| MousePheno | abnormal interdigital cell death | 2.52e-04 | 5 | 71 | 2 | MP:0009874 | |
| MousePheno | abnormal jaw morphology | 3.25e-04 | 530 | 71 | 10 | MP:0000454 | |
| MousePheno | impaired long-term object recognition memory | 3.76e-04 | 28 | 71 | 3 | MP:0014367 | |
| MousePheno | micrognathia | 3.89e-04 | 68 | 71 | 4 | MP:0002639 | |
| MousePheno | abnormal vertebrae morphology | TRIM45 HSPG2 FRAS1 ESR1 MBD1 LTBP3 BMPER EZH2 PLEKHM1 NOTCH2 | 4.11e-04 | 546 | 71 | 10 | MP:0000137 |
| MousePheno | abnormal compact bone area | 4.17e-04 | 29 | 71 | 3 | MP:0010966 | |
| MousePheno | abnormal innervation | 4.36e-04 | 193 | 71 | 6 | MP:0002184 | |
| MousePheno | abnormal nervous system development | EBF2 HSPG2 ERBB2 EGFR DCTN5 MBD1 LRRTM4 LRP2 LAMA2 ZMYM2 EBF1 BMPER ITGB1 SFMBT2 DISP1 NOTCH3 | 4.58e-04 | 1257 | 71 | 16 | MP:0003861 |
| MousePheno | abnormal neuron number | 4.78e-04 | 456 | 71 | 9 | MP:0008946 | |
| MousePheno | decreased volumetric bone mineral density | 5.25e-04 | 7 | 71 | 2 | MP:0013616 | |
| MousePheno | abnormal cochlear hair cell morphology | 5.55e-04 | 202 | 71 | 6 | MP:0002622 | |
| MousePheno | hearing/vestibular/ear phenotype | HSPG2 THRB EGFR OTOGL ESR2 TMEM63B LRP2 LAMA2 GRXCR1 BMPER USH2A NOTCH3 OTOG | 5.60e-04 | 905 | 71 | 13 | MP:0005377 |
| MousePheno | abnormal tectorial membrane morphology | 5.60e-04 | 32 | 71 | 3 | MP:0003149 | |
| MousePheno | abnormal postnatal growth | EBF2 KMT2C RIF1 FRAS1 THRB EGFR ESR1 LAMA2 KIF4A KIF4B LTBP3 SMOC1 EZH2 | 5.72e-04 | 907 | 71 | 13 | MP:0001731 |
| MousePheno | abnormal tibia morphology | 6.06e-04 | 375 | 71 | 8 | MP:0000558 | |
| MousePheno | thin epidermis | 6.14e-04 | 33 | 71 | 3 | MP:0001218 | |
| MousePheno | decreased neuron number | 6.17e-04 | 376 | 71 | 8 | MP:0008948 | |
| MousePheno | enlarged heart | EBF2 ERBB2 EGFR ESR2 LRP1 LRP2 EBF1 GRIN2B SMOC1 C9 EZH2 NOTCH3 SSUH2 | 6.28e-04 | 916 | 71 | 13 | MP:0000274 |
| MousePheno | abnormal cochlear sensory epithelium morphology | 6.31e-04 | 207 | 71 | 6 | MP:0003308 | |
| MousePheno | abnormal organ of Corti morphology | 6.63e-04 | 209 | 71 | 6 | MP:0000042 | |
| MousePheno | abnormal hindlimb zeugopod morphology | 6.72e-04 | 381 | 71 | 8 | MP:0003857 | |
| MousePheno | behavioral developmental delay | 6.98e-04 | 8 | 71 | 2 | MP:0021165 | |
| MousePheno | abnormal heart size | EBF2 ERBB2 EGFR ESR1 ESR2 LRP1 LRP2 EBF1 GRIN2B SMOC1 C9 EZH2 NOTCH2 NOTCH3 SSUH2 | 7.24e-04 | 1180 | 71 | 15 | MP:0005406 |
| MousePheno | abnormal telencephalon morphology | EBF2 HSPG2 EGFR EBF3 ESR2 MBD1 LRRTM4 LRP2 KIF4A KIF4B EBF1 GRIN2B | 7.31e-04 | 812 | 71 | 12 | MP:0000787 |
| MousePheno | abnormal viscerocranium morphology | 7.82e-04 | 593 | 71 | 10 | MP:0005274 | |
| MousePheno | absent parietal bone | 8.95e-04 | 9 | 71 | 2 | MP:0004419 | |
| MousePheno | iris coloboma | 8.95e-04 | 9 | 71 | 2 | MP:0010714 | |
| MousePheno | impaired hearing | 9.30e-04 | 223 | 71 | 6 | MP:0006325 | |
| MousePheno | abnormal cranial nerve morphology | 1.05e-03 | 314 | 71 | 7 | MP:0001056 | |
| MousePheno | abnormal prenatal growth/weight/body size | HSPG2 RIF1 THRB EGFR LRP1 LRP2 ZMYM2 KIF4A KIF4B BMPER SMOC1 EZH2 HNF4A ITGB1 SFMBT2 DISP1 NOTCH2 | 1.06e-03 | 1493 | 71 | 17 | MP:0004196 |
| MousePheno | abnormal basement membrane morphology | 1.08e-03 | 40 | 71 | 3 | MP:0004272 | |
| MousePheno | increased compact bone area | 1.11e-03 | 10 | 71 | 2 | MP:0010967 | |
| MousePheno | clubfoot | 1.11e-03 | 10 | 71 | 2 | MP:0000576 | |
| MousePheno | abnormal dendritic spine number | 1.11e-03 | 10 | 71 | 2 | MP:0021017 | |
| MousePheno | increased compact bone thickness | 1.17e-03 | 41 | 71 | 3 | MP:0004148 | |
| MousePheno | abnormal craniofacial morphology | EBF2 HSPG2 FRAS1 THRB EGFR DCTN5 LRP1 LRP2 LAMA2 LTBP3 BMPER SMOC1 ITGB1 SFMBT2 DISP1 SSUH2 | 1.19e-03 | 1372 | 71 | 16 | MP:0000428 |
| Domain | EGF_1 | HSPG2 STAB2 HMCN1 SUSD1 ADAM9 LRP1 LRP2 LAMA2 ADAM30 ADAM2 LTBP3 C8A C9 ADAM12 USH2A ITGB1 ADAM22 NOTCH2 NOTCH3 STAB1 | 1.96e-19 | 255 | 86 | 20 | PS00022 |
| Domain | Growth_fac_rcpt_ | HSPG2 ERBB2 FRAS1 STAB2 HMCN1 CCN1 EGFR SUSD1 LRP1 LRP2 RSPO4 LTBP3 C8A C9 NOTCH2 NOTCH3 STAB1 | 4.67e-19 | 156 | 86 | 17 | IPR009030 |
| Domain | EGF-like_dom | HSPG2 FRAS1 STAB2 HMCN1 SUSD1 ADAM9 LRP1 LRP2 LAMA2 ADAM30 LTBP3 C8A C9 ADAM12 ADAM22 NOTCH2 NOTCH3 OTOG STAB1 | 2.92e-18 | 249 | 86 | 19 | IPR000742 |
| Domain | EGF_3 | HSPG2 STAB2 HMCN1 SUSD1 ADAM9 LRP1 LRP2 ADAM30 ADAM2 LTBP3 C8A C9 ADAM12 ADAM22 NOTCH2 NOTCH3 OTOG STAB1 | 2.32e-17 | 235 | 86 | 18 | PS50026 |
| Domain | EGF-like_CS | HSPG2 STAB2 HMCN1 SUSD1 ADAM9 LRP1 LRP2 LAMA2 ADAM30 LTBP3 C8A C9 ADAM12 ITGB1 ADAM22 NOTCH2 NOTCH3 STAB1 | 1.50e-16 | 261 | 86 | 18 | IPR013032 |
| Domain | EGF_2 | HSPG2 STAB2 HMCN1 SUSD1 ADAM9 LRP1 LRP2 LAMA2 ADAM30 ADAM2 LTBP3 C8A C9 ADAM12 ADAM22 NOTCH2 NOTCH3 STAB1 | 1.96e-16 | 265 | 86 | 18 | PS01186 |
| Domain | EGF | HSPG2 FRAS1 STAB2 HMCN1 SUSD1 ADAM9 LRP1 LRP2 LAMA2 LTBP3 ADAM22 NOTCH2 NOTCH3 STAB1 | 3.44e-12 | 235 | 86 | 14 | SM00181 |
| Domain | EGF_CA | 2.27e-10 | 122 | 86 | 10 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.67e-10 | 124 | 86 | 10 | IPR001881 | |
| Domain | EGF_extracell | 3.05e-10 | 60 | 86 | 8 | IPR013111 | |
| Domain | EGF_2 | 3.05e-10 | 60 | 86 | 8 | PF07974 | |
| Domain | Tesmin/TSO1-like_CXC | 6.24e-09 | 6 | 86 | 4 | IPR033467 | |
| Domain | CXC | 6.24e-09 | 6 | 86 | 4 | SM01114 | |
| Domain | Disintegrin_CS | 7.72e-09 | 16 | 86 | 5 | IPR018358 | |
| Domain | ADAM_CR | 1.50e-08 | 18 | 86 | 5 | PF08516 | |
| Domain | - | 2.70e-08 | 20 | 86 | 5 | 4.10.70.10 | |
| Domain | LDLR_class-A_CS | 2.70e-08 | 40 | 86 | 6 | IPR023415 | |
| Domain | Disintegrin | 3.53e-08 | 21 | 86 | 5 | PF00200 | |
| Domain | DISIN | 3.53e-08 | 21 | 86 | 5 | SM00050 | |
| Domain | Ldl_recept_a | 5.63e-08 | 45 | 86 | 6 | PF00057 | |
| Domain | - | 6.45e-08 | 46 | 86 | 6 | 4.10.400.10 | |
| Domain | LDLRA_1 | 8.39e-08 | 48 | 86 | 6 | PS01209 | |
| Domain | LDLRA_2 | 9.53e-08 | 49 | 86 | 6 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 9.53e-08 | 49 | 86 | 6 | IPR002172 | |
| Domain | LDLa | 9.53e-08 | 49 | 86 | 6 | SM00192 | |
| Domain | EGF | 1.17e-07 | 126 | 86 | 8 | PF00008 | |
| Domain | - | 1.35e-07 | 11 | 86 | 4 | 2.40.155.10 | |
| Domain | GFP-like | 1.35e-07 | 11 | 86 | 4 | IPR023413 | |
| Domain | EGF_CA | 1.37e-07 | 86 | 86 | 7 | PF07645 | |
| Domain | ACR | 1.37e-07 | 27 | 86 | 5 | SM00608 | |
| Domain | ADAM_Cys-rich | 1.37e-07 | 27 | 86 | 5 | IPR006586 | |
| Domain | EGF_LAM_2 | 2.40e-07 | 30 | 86 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 2.40e-07 | 30 | 86 | 5 | PS01248 | |
| Domain | EGF_Ca-bd_CS | 3.15e-07 | 97 | 86 | 7 | IPR018097 | |
| Domain | EGF_CA | 3.62e-07 | 99 | 86 | 7 | PS01187 | |
| Domain | Transcription_factor_COE | 3.76e-07 | 4 | 86 | 3 | IPR003523 | |
| Domain | COE_HLH | 3.76e-07 | 4 | 86 | 3 | IPR032201 | |
| Domain | COE_DBD | 3.76e-07 | 4 | 86 | 3 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 3.76e-07 | 4 | 86 | 3 | IPR018350 | |
| Domain | COE1_HLH | 3.76e-07 | 4 | 86 | 3 | PF16423 | |
| Domain | COE1_DBD | 3.76e-07 | 4 | 86 | 3 | PF16422 | |
| Domain | COE | 3.76e-07 | 4 | 86 | 3 | PS01345 | |
| Domain | ASX_HYDROXYL | 3.88e-07 | 100 | 86 | 7 | PS00010 | |
| Domain | TSP1 | 5.31e-07 | 65 | 86 | 6 | SM00209 | |
| Domain | TSP1_rpt | 5.31e-07 | 65 | 86 | 6 | IPR000884 | |
| Domain | TSP1 | 5.31e-07 | 65 | 86 | 6 | PS50092 | |
| Domain | EGF_Lam | 5.36e-07 | 35 | 86 | 5 | SM00180 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.77e-07 | 106 | 86 | 7 | IPR000152 | |
| Domain | Laminin_EGF | 8.20e-07 | 38 | 86 | 5 | IPR002049 | |
| Domain | Peptidase_M12B_N | 9.37e-07 | 39 | 86 | 5 | IPR002870 | |
| Domain | Pep_M12B_propep | 9.37e-07 | 39 | 86 | 5 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.07e-06 | 40 | 86 | 5 | PS00427 | |
| Domain | Reprolysin | 1.07e-06 | 40 | 86 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 1.07e-06 | 40 | 86 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.07e-06 | 40 | 86 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 1.07e-06 | 40 | 86 | 5 | IPR001590 | |
| Domain | Disintegrin_dom | 1.21e-06 | 41 | 86 | 5 | IPR001762 | |
| Domain | Furin_repeat | 1.22e-06 | 18 | 86 | 4 | IPR006212 | |
| Domain | FU | 1.22e-06 | 18 | 86 | 4 | SM00261 | |
| Domain | zf-C4 | 2.17e-06 | 46 | 86 | 5 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 2.17e-06 | 46 | 86 | 5 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 2.17e-06 | 46 | 86 | 5 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 2.17e-06 | 46 | 86 | 5 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 2.17e-06 | 46 | 86 | 5 | PS00031 | |
| Domain | ZnF_C4 | 2.17e-06 | 46 | 86 | 5 | SM00399 | |
| Domain | - | 2.42e-06 | 47 | 86 | 5 | 1.10.565.10 | |
| Domain | HOLI | 2.70e-06 | 48 | 86 | 5 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 2.70e-06 | 48 | 86 | 5 | IPR000536 | |
| Domain | Hormone_recep | 2.70e-06 | 48 | 86 | 5 | PF00104 | |
| Domain | cEGF | 5.80e-06 | 26 | 86 | 4 | IPR026823 | |
| Domain | cEGF | 5.80e-06 | 26 | 86 | 4 | PF12662 | |
| Domain | - | 6.38e-06 | 57 | 86 | 5 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 6.96e-06 | 58 | 86 | 5 | IPR013088 | |
| Domain | TSP_1 | 1.05e-05 | 63 | 86 | 5 | PF00090 | |
| Domain | C1 | 1.22e-05 | 65 | 86 | 5 | SM00109 | |
| Domain | PE/DAG-bd | 1.32e-05 | 66 | 86 | 5 | IPR002219 | |
| Domain | Laminin_EGF | 1.97e-05 | 35 | 86 | 4 | PF00053 | |
| Domain | TIL_dom | 3.31e-05 | 14 | 86 | 3 | IPR002919 | |
| Domain | MetalloPept_cat_dom | 3.58e-05 | 81 | 86 | 5 | IPR024079 | |
| Domain | - | 3.58e-05 | 81 | 86 | 5 | 3.40.390.10 | |
| Domain | VWF_dom | 4.10e-05 | 42 | 86 | 4 | IPR001007 | |
| Domain | ZnF_NFX | 6.27e-05 | 3 | 86 | 2 | SM00438 | |
| Domain | DUF3454 | 6.27e-05 | 3 | 86 | 2 | PF11936 | |
| Domain | DUF3454_notch | 6.27e-05 | 3 | 86 | 2 | IPR024600 | |
| Domain | zf-NF-X1 | 6.27e-05 | 3 | 86 | 2 | PF01422 | |
| Domain | Znf_NFX1 | 6.27e-05 | 3 | 86 | 2 | IPR000967 | |
| Domain | DUF3454 | 6.27e-05 | 3 | 86 | 2 | SM01334 | |
| Domain | FAS1 | 1.25e-04 | 4 | 86 | 2 | SM00554 | |
| Domain | Notch | 1.25e-04 | 4 | 86 | 2 | IPR008297 | |
| Domain | FAS1_domain | 1.25e-04 | 4 | 86 | 2 | IPR000782 | |
| Domain | NODP | 1.25e-04 | 4 | 86 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.25e-04 | 4 | 86 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.25e-04 | 4 | 86 | 2 | IPR010660 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 1.25e-04 | 4 | 86 | 2 | IPR016245 | |
| Domain | - | 1.25e-04 | 4 | 86 | 2 | 2.30.180.10 | |
| Domain | NOD | 1.25e-04 | 4 | 86 | 2 | PF06816 | |
| Domain | FAS1 | 1.25e-04 | 4 | 86 | 2 | PS50213 | |
| Domain | Fasciclin | 1.25e-04 | 4 | 86 | 2 | PF02469 | |
| Domain | NOD | 1.25e-04 | 4 | 86 | 2 | SM01338 | |
| Domain | NODP | 1.25e-04 | 4 | 86 | 2 | SM01339 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.07e-06 | 38 | 69 | 5 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.07e-06 | 38 | 69 | 5 | MM15865 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 3.53e-06 | 48 | 69 | 5 | MM14987 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 5.80e-06 | 53 | 69 | 5 | M8276 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION | 9.23e-06 | 9 | 69 | 3 | M47881 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 1.93e-05 | 33 | 69 | 4 | M39455 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 3.10e-05 | 13 | 69 | 3 | M47534 | |
| Pathway | REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS | 4.90e-05 | 15 | 69 | 3 | M27766 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 5.11e-05 | 42 | 69 | 4 | M174 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 6.00e-05 | 16 | 69 | 3 | M29847 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 7.35e-05 | 46 | 69 | 4 | M239 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586 | 7.35e-05 | 46 | 69 | 4 | M39661 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 8.69e-05 | 48 | 69 | 4 | M27642 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.05e-04 | 154 | 69 | 6 | M39739 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 1.85e-04 | 23 | 69 | 3 | MM1480 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 1.85e-04 | 23 | 69 | 3 | M18719 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.95e-04 | 59 | 69 | 4 | M27218 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 2.11e-04 | 24 | 69 | 3 | M11190 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 2.11e-04 | 24 | 69 | 3 | M15926 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 2.34e-04 | 5 | 69 | 2 | M27411 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 2.39e-04 | 25 | 69 | 3 | M118 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 2.69e-04 | 26 | 69 | 3 | M29535 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 2.69e-04 | 26 | 69 | 3 | MM15501 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 3.37e-04 | 28 | 69 | 3 | MM15042 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.38e-04 | 68 | 69 | 4 | MM14968 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 3.50e-04 | 6 | 69 | 2 | M27068 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 3.74e-04 | 29 | 69 | 3 | MM1522 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 3.74e-04 | 29 | 69 | 3 | M27756 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 4.14e-04 | 30 | 69 | 3 | M27323 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.14e-04 | 30 | 69 | 3 | M27216 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 4.57e-04 | 31 | 69 | 3 | MM1343 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION | 4.88e-04 | 7 | 69 | 2 | M47873 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 4.88e-04 | 7 | 69 | 2 | M47805 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY | 4.88e-04 | 7 | 69 | 2 | M47431 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.03e-04 | 32 | 69 | 3 | MM14854 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.17e-04 | 76 | 69 | 4 | M27219 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 5.51e-04 | 33 | 69 | 3 | M6220 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.43e-04 | 300 | 69 | 7 | M610 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 6.49e-04 | 8 | 69 | 2 | MM14656 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 6.49e-04 | 8 | 69 | 2 | M27006 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 7.22e-04 | 83 | 69 | 4 | M27163 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.55e-04 | 84 | 69 | 4 | M7098 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 7.74e-04 | 37 | 69 | 3 | M27134 | |
| Pathway | WP_CANCER_PATHWAYS | 7.79e-04 | 507 | 69 | 9 | M48302 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 8.31e-04 | 9 | 69 | 2 | M22072 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 8.37e-04 | 38 | 69 | 3 | M27757 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 9.04e-04 | 39 | 69 | 3 | MM14601 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.09e-03 | 532 | 69 | 9 | M27870 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EBF2 KMT2C ERBB2 EGFR LPL MYRIP LAMA2 KIF4A KIF4B RPS26 EBF1 GRIN2B EZH2 HNF4A ITGB1 ADAM22 | 1.24e-03 | 1432 | 69 | 16 | M509 |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.24e-03 | 96 | 69 | 4 | M39581 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 1.26e-03 | 11 | 69 | 2 | M18837 | |
| Pathway | REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA | 1.26e-03 | 11 | 69 | 2 | M27184 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.26e-03 | 11 | 69 | 2 | M47865 | |
| Pathway | REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA | 1.26e-03 | 11 | 69 | 2 | MM14897 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 1.26e-03 | 11 | 69 | 2 | M29814 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 1.26e-03 | 11 | 69 | 2 | MM1432 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.26e-03 | 11 | 69 | 2 | MM15478 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 1.26e-03 | 11 | 69 | 2 | M47503 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.29e-03 | 44 | 69 | 3 | M26969 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.29e-03 | 44 | 69 | 3 | MM14520 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.37e-03 | 45 | 69 | 3 | MM15344 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.45e-03 | 100 | 69 | 4 | M27158 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.51e-03 | 12 | 69 | 2 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 1.51e-03 | 12 | 69 | 2 | M47798 | |
| Pathway | WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY | 1.51e-03 | 12 | 69 | 2 | M48316 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.51e-03 | 12 | 69 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.51e-03 | 12 | 69 | 2 | M47533 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4 | 1.78e-03 | 13 | 69 | 2 | M39582 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.78e-03 | 13 | 69 | 2 | M27729 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.78e-03 | 13 | 69 | 2 | M47423 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 1.78e-03 | 13 | 69 | 2 | MM15320 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 1.78e-03 | 13 | 69 | 2 | M42551 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.78e-03 | 13 | 69 | 2 | M4732 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.87e-03 | 50 | 69 | 3 | M553 | |
| Pathway | WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL | 1.98e-03 | 51 | 69 | 3 | M39754 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 2.05e-03 | 110 | 69 | 4 | M27162 | |
| Pathway | WP_SULFATASE_AND_AROMATASE_PATHWAY | 2.07e-03 | 14 | 69 | 2 | M48085 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.07e-03 | 14 | 69 | 2 | MM14923 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 2.07e-03 | 14 | 69 | 2 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 2.07e-03 | 14 | 69 | 2 | MM14531 | |
| Pathway | WP_FOCAL_ADHESION | 2.20e-03 | 187 | 69 | 5 | MM15913 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 2.27e-03 | 113 | 69 | 4 | MM14783 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 2.38e-03 | 15 | 69 | 2 | M201 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 2.38e-03 | 15 | 69 | 2 | M29701 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5 | 2.38e-03 | 15 | 69 | 2 | M42552 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 2.38e-03 | 15 | 69 | 2 | M27608 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.38e-03 | 15 | 69 | 2 | M7146 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA | 2.45e-03 | 55 | 69 | 3 | M41823 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 2.65e-03 | 118 | 69 | 4 | M713 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 2.71e-03 | 16 | 69 | 2 | M47381 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 2.71e-03 | 16 | 69 | 2 | M47801 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 2.71e-03 | 16 | 69 | 2 | M562 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 2.71e-03 | 16 | 69 | 2 | M570 | |
| Pathway | WP_FOCAL_ADHESION | 2.88e-03 | 199 | 69 | 5 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.88e-03 | 199 | 69 | 5 | M7253 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.90e-03 | 121 | 69 | 4 | M872 | |
| Pathway | WP_OREXIN_RECEPTOR_PATHWAY | 2.95e-03 | 200 | 69 | 5 | M48048 | |
| Pathway | PID_NOTCH_PATHWAY | 3.00e-03 | 59 | 69 | 3 | M17 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 3.06e-03 | 17 | 69 | 2 | M212 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 3.06e-03 | 17 | 69 | 2 | MM15944 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CDC37 TRAF7 HSPG2 ERBB2 FRAS1 CCN1 EGFR ADAM9 LPL LRP1 KIF4A LTBP3 BMPER SMOC1 ADAM12 ITGB1 ADAM22 NOTCH2 NOTCH3 | 2.06e-10 | 1201 | 90 | 19 | 35696571 |
| Pubmed | 7.12e-10 | 71 | 90 | 7 | 33541421 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 8.65e-09 | 101 | 90 | 7 | 23382219 | |
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 25203051 | ||
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 26592768 | ||
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 19706809 | ||
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 9151732 | ||
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 34190995 | ||
| Pubmed | Plasma membrane estrogen receptors exist and functions as dimers. | 1.68e-08 | 3 | 90 | 3 | 15231873 | |
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 28947799 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 6.06e-08 | 79 | 90 | 6 | 18757743 | |
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 21152100 | ||
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 21901395 | ||
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 9151733 | ||
| Pubmed | Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection. | 6.69e-08 | 4 | 90 | 3 | 12139918 | |
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 21749714 | ||
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 22394363 | ||
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 24269135 | ||
| Pubmed | Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool? | 6.69e-08 | 4 | 90 | 3 | 21762477 | |
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 19657752 | ||
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 12917357 | ||
| Pubmed | Ser-884 adjacent to the LXXLL motif of coactivator TRBP defines selectivity for ERs and TRs. | 1.67e-07 | 5 | 90 | 3 | 11773444 | |
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 15261831 | ||
| Pubmed | 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. | 1.67e-07 | 5 | 90 | 3 | 17873880 | |
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 19636371 | ||
| Pubmed | ERbeta Binds N-CoR in the Presence of Estrogens via an LXXLL-like Motif in the N-CoR C-terminus. | 1.67e-07 | 5 | 90 | 3 | 12904255 | |
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 19676041 | ||
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 19882362 | ||
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 2.43e-07 | 21 | 90 | 4 | 22767514 | |
| Pubmed | ERAP140, a conserved tissue-specific nuclear receptor coactivator. | 3.33e-07 | 6 | 90 | 3 | 11971969 | |
| Pubmed | Estrogen receptor, a common interaction partner for a subset of nuclear receptors. | 3.33e-07 | 6 | 90 | 3 | 9717844 | |
| Pubmed | 3.33e-07 | 6 | 90 | 3 | 9389446 | ||
| Pubmed | 3.33e-07 | 6 | 90 | 3 | 11882657 | ||
| Pubmed | 3.33e-07 | 6 | 90 | 3 | 11279242 | ||
| Pubmed | Role of multiple beta1 integrins in cell adhesion to the disintegrin domains of ADAMs 2 and 3. | 5.82e-07 | 7 | 90 | 3 | 14516789 | |
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 5.82e-07 | 7 | 90 | 3 | 24786561 | |
| Pubmed | 5.82e-07 | 7 | 90 | 3 | 19720911 | ||
| Pubmed | 7.01e-07 | 64 | 90 | 5 | 22261194 | ||
| Pubmed | 9.30e-07 | 8 | 90 | 3 | 26350464 | ||
| Pubmed | 9.30e-07 | 8 | 90 | 3 | 14993187 | ||
| Pubmed | 9.30e-07 | 8 | 90 | 3 | 25202019 | ||
| Pubmed | Cloning and characterization of RAP250, a novel nuclear receptor coactivator. | 9.30e-07 | 8 | 90 | 3 | 10681503 | |
| Pubmed | 9.48e-07 | 29 | 90 | 4 | 22613833 | ||
| Pubmed | 1.25e-06 | 31 | 90 | 4 | 22274697 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KMT2C ERBB2 SLC8B1 THRB TESMIN EGFR TMEM63B LRP1 MYRIP RBM5 PRKD1 ITGB1 SFMBT2 PLEKHM1 NOTCH2 NOTCH3 | 1.26e-06 | 1489 | 90 | 16 | 28611215 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RIF1 EBF3 MBD1 LRP1 NFXL1 ZMYM2 KIF4A ITGB1 ZMYM3 NOTCH2 NOTCH3 ARMC6 | 2.19e-06 | 857 | 90 | 12 | 25609649 |
| Pubmed | Integrative predictive model of coronary artery calcification in atherosclerosis. | 2.30e-06 | 229 | 90 | 7 | 19948975 | |
| Pubmed | Control of hindbrain motor neuron differentiation by the homeobox gene Phox2b. | 2.72e-06 | 11 | 90 | 3 | 10704382 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZNF276 THRB EBF3 ESR1 ESR2 MBD1 NFX1 ZMYM2 NR1H2 EBF1 EZH2 HNF4A | 2.77e-06 | 877 | 90 | 12 | 20211142 |
| Pubmed | 3.62e-06 | 12 | 90 | 3 | 11158331 | ||
| Pubmed | 3.62e-06 | 12 | 90 | 3 | 30658714 | ||
| Pubmed | Transient and lineage-restricted requirement of Ebf3 for sternum ossification. | 3.62e-06 | 12 | 90 | 3 | 32398354 | |
| Pubmed | 3.62e-06 | 12 | 90 | 3 | 16453284 | ||
| Pubmed | 4.70e-06 | 13 | 90 | 3 | 22421355 | ||
| Pubmed | Control of the migratory pathway of facial branchiomotor neurones. | 4.70e-06 | 13 | 90 | 3 | 11076752 | |
| Pubmed | Notch signaling coordinates the patterning of striatal compartments. | 4.70e-06 | 13 | 90 | 3 | 16120638 | |
| Pubmed | 4.91e-06 | 257 | 90 | 7 | 16335952 | ||
| Pubmed | 5.00e-06 | 167 | 90 | 6 | 22159717 | ||
| Pubmed | 5.97e-06 | 14 | 90 | 3 | 19240213 | ||
| Pubmed | Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. | 5.97e-06 | 14 | 90 | 3 | 12039952 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 23391338 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 29655286 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19200973 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 6.62e-06 | 2 | 90 | 2 | 36482480 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 25349977 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 11826769 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 21986939 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 23871709 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 26986538 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19285805 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 22038234 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 33159119 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16118406 | ||
| Pubmed | Expression of aromatase and estrogen receptors in lumbar motoneurons of mice. | 6.62e-06 | 2 | 90 | 2 | 28501695 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20372779 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20032008 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 10919284 | ||
| Pubmed | Estrogen Receptor Expression in Pancreatic Adenocarcinoma: Time to Reconsider Evidence. | 6.62e-06 | 2 | 90 | 2 | 34860807 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16735942 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 26709918 | ||
| Pubmed | Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. | 6.62e-06 | 2 | 90 | 2 | 16880783 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17889406 | ||
| Pubmed | HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer. | 6.62e-06 | 2 | 90 | 2 | 23594562 | |
| Pubmed | Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia. | 6.62e-06 | 2 | 90 | 2 | 17924141 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 1706616 | ||
| Pubmed | Pregnancy and oestrogen regulate sinoatrial node calcium homeostasis and accelerate pacemaking. | 6.62e-06 | 2 | 90 | 2 | 29800268 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 11014235 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19003958 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19946741 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 38416376 | ||
| Pubmed | Evolutionary analysis of the ErbB receptor and ligand families. | 6.62e-06 | 2 | 90 | 2 | 10824084 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20850223 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 11557741 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 12952206 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 25589492 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 28368450 | ||
| Pubmed | Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. | 6.62e-06 | 2 | 90 | 2 | 15698835 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15143334 | ||
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 6.62e-06 | 2 | 90 | 2 | 30081192 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 30093109 | ||
| Interaction | TAF5L interactions | 4.70e-07 | 107 | 89 | 7 | int:TAF5L | |
| Interaction | ADAM2 interactions | 8.09e-07 | 17 | 89 | 4 | int:ADAM2 | |
| Interaction | PSMC3IP interactions | 9.91e-07 | 41 | 89 | 5 | int:PSMC3IP | |
| Interaction | ZDHHC15 interactions | 1.35e-06 | 125 | 89 | 7 | int:ZDHHC15 | |
| Interaction | ZNF146 interactions | 3.09e-06 | 91 | 89 | 6 | int:ZNF146 | |
| Interaction | CD58 interactions | 3.53e-06 | 24 | 89 | 4 | int:CD58 | |
| Interaction | NTN5 interactions | 3.53e-06 | 24 | 89 | 4 | int:NTN5 | |
| Interaction | CHD7 interactions | 4.55e-06 | 150 | 89 | 7 | int:CHD7 | |
| Interaction | ZFP41 interactions | 5.24e-06 | 57 | 89 | 5 | int:ZFP41 | |
| Interaction | ZNF777 interactions | 5.35e-06 | 100 | 89 | 6 | int:ZNF777 | |
| Interaction | MUC4 interactions | 6.86e-06 | 9 | 89 | 3 | int:MUC4 | |
| Interaction | KIF4A interactions | 8.34e-06 | 108 | 89 | 6 | int:KIF4A | |
| Interaction | LIN9 interactions | 9.77e-06 | 111 | 89 | 6 | int:LIN9 | |
| Interaction | HDAC3 interactions | 1.00e-05 | 313 | 89 | 9 | int:HDAC3 | |
| Interaction | EGF interactions | 1.02e-05 | 31 | 89 | 4 | int:EGF | |
| Interaction | ZMYM4 interactions | 1.08e-05 | 171 | 89 | 7 | int:ZMYM4 | |
| Interaction | TNC interactions | 1.16e-05 | 32 | 89 | 4 | int:TNC | |
| Interaction | PPARGC1B interactions | 1.16e-05 | 32 | 89 | 4 | int:PPARGC1B | |
| Interaction | LGALS8 interactions | 1.20e-05 | 174 | 89 | 7 | int:LGALS8 | |
| Interaction | FBXO2 interactions | 1.35e-05 | 411 | 89 | 10 | int:FBXO2 | |
| Interaction | LRWD1 interactions | 1.39e-05 | 118 | 89 | 6 | int:LRWD1 | |
| Interaction | ANKS1B interactions | 1.49e-05 | 34 | 89 | 4 | int:ANKS1B | |
| Interaction | STAT1 interactions | 2.03e-05 | 342 | 89 | 9 | int:STAT1 | |
| Interaction | IGFL3 interactions | 2.03e-05 | 75 | 89 | 5 | int:IGFL3 | |
| Interaction | CRYBG1 interactions | 2.03e-05 | 75 | 89 | 5 | int:CRYBG1 | |
| Interaction | CCN2 interactions | 2.88e-05 | 40 | 89 | 4 | int:CCN2 | |
| Interaction | NR0B1 interactions | 2.88e-05 | 40 | 89 | 4 | int:NR0B1 | |
| Interaction | ZNF592 interactions | 2.95e-05 | 81 | 89 | 5 | int:ZNF592 | |
| Interaction | DYRK1A interactions | CCN1 ADAM9 ESR1 ESR2 TMEM63B LRP2 LTBP3 RPS26 ADAM22 NOTCH2 STAB1 | 3.12e-05 | 552 | 89 | 11 | int:DYRK1A |
| Interaction | PPARGC1A interactions | 3.13e-05 | 82 | 89 | 5 | int:PPARGC1A | |
| Interaction | ZMYM3 interactions | 3.23e-05 | 137 | 89 | 6 | int:ZMYM3 | |
| Interaction | NR0B2 interactions | 3.32e-05 | 83 | 89 | 5 | int:NR0B2 | |
| Interaction | ATF7IP interactions | 3.37e-05 | 138 | 89 | 6 | int:ATF7IP | |
| Interaction | CEBPZ interactions | 3.44e-05 | 281 | 89 | 8 | int:CEBPZ | |
| Interaction | MED1 interactions | 3.57e-05 | 206 | 89 | 7 | int:MED1 | |
| Interaction | ADAM7 interactions | 3.84e-05 | 43 | 89 | 4 | int:ADAM7 | |
| Interaction | ORC5 interactions | 4.17e-05 | 87 | 89 | 5 | int:ORC5 | |
| Interaction | ZNF408 interactions | 4.45e-05 | 145 | 89 | 6 | int:ZNF408 | |
| Interaction | NCOA6 interactions | 4.45e-05 | 145 | 89 | 6 | int:NCOA6 | |
| Interaction | ADAM23 interactions | 4.47e-05 | 16 | 89 | 3 | int:ADAM23 | |
| Interaction | GTF3C3 interactions | 4.55e-05 | 214 | 89 | 7 | int:GTF3C3 | |
| Interaction | SIN3A interactions | 4.61e-05 | 380 | 89 | 9 | int:SIN3A | |
| Interaction | NCOA1 interactions | 4.62e-05 | 146 | 89 | 6 | int:NCOA1 | |
| Interaction | ITGB5 interactions | 4.80e-05 | 147 | 89 | 6 | int:ITGB5 | |
| Interaction | MORC2 interactions | 5.17e-05 | 91 | 89 | 5 | int:MORC2 | |
| Interaction | CD59 interactions | 5.45e-05 | 92 | 89 | 5 | int:CD59 | |
| Interaction | ADAM19 interactions | 5.96e-05 | 48 | 89 | 4 | int:ADAM19 | |
| Interaction | NCOA3 interactions | 6.07e-05 | 224 | 89 | 7 | int:NCOA3 | |
| Interaction | ZNF276 interactions | 6.47e-05 | 49 | 89 | 4 | int:ZNF276 | |
| Interaction | PATE1 interactions | 6.47e-05 | 49 | 89 | 4 | int:PATE1 | |
| Interaction | ADAM28 interactions | 6.48e-05 | 18 | 89 | 3 | int:ADAM28 | |
| Interaction | ZNHIT3 interactions | 7.01e-05 | 50 | 89 | 4 | int:ZNHIT3 | |
| Interaction | WDR43 interactions | 7.43e-05 | 159 | 89 | 6 | int:WDR43 | |
| Interaction | ORC3 interactions | 8.51e-05 | 101 | 89 | 5 | int:ORC3 | |
| Interaction | MAML3 interactions | 8.99e-05 | 20 | 89 | 3 | int:MAML3 | |
| Interaction | BLM interactions | 9.12e-05 | 239 | 89 | 7 | int:BLM | |
| Interaction | SMOC1 interactions | 9.49e-05 | 54 | 89 | 4 | int:SMOC1 | |
| Interaction | MUC1 interactions | 1.01e-04 | 168 | 89 | 6 | int:MUC1 | |
| Interaction | SHANK2 interactions | 1.02e-04 | 55 | 89 | 4 | int:SHANK2 | |
| Interaction | NOTCH2 interactions | 1.05e-04 | 423 | 89 | 9 | int:NOTCH2 | |
| Interaction | PDS5A interactions | 1.06e-04 | 245 | 89 | 7 | int:PDS5A | |
| Interaction | LGALS1 interactions | 1.11e-04 | 332 | 89 | 8 | int:LGALS1 | |
| Interaction | EIF3K interactions | 1.11e-04 | 171 | 89 | 6 | int:EIF3K | |
| Interaction | SUB1 interactions | 1.12e-04 | 247 | 89 | 7 | int:SUB1 | |
| Interaction | ADAM20 interactions | 1.15e-04 | 4 | 89 | 2 | int:ADAM20 | |
| Interaction | C8A interactions | 1.21e-04 | 22 | 89 | 3 | int:C8A | |
| Interaction | MAPK8IP1 interactions | 1.26e-04 | 58 | 89 | 4 | int:MAPK8IP1 | |
| Interaction | ADAM12 interactions | 1.26e-04 | 58 | 89 | 4 | int:ADAM12 | |
| Interaction | TASOR interactions | 1.27e-04 | 110 | 89 | 5 | int:TASOR | |
| Interaction | BEND3 interactions | 1.33e-04 | 111 | 89 | 5 | int:BEND3 | |
| Interaction | RBPJ interactions | 1.33e-04 | 254 | 89 | 7 | int:RBPJ | |
| Interaction | AP1S1 interactions | 1.34e-04 | 59 | 89 | 4 | int:AP1S1 | |
| Interaction | EMG1 interactions | 1.45e-04 | 113 | 89 | 5 | int:EMG1 | |
| Interaction | CD82 interactions | 1.53e-04 | 61 | 89 | 4 | int:CD82 | |
| Interaction | MAPK8IP2 interactions | 1.57e-04 | 115 | 89 | 5 | int:MAPK8IP2 | |
| Interaction | KLK9 interactions | 1.58e-04 | 24 | 89 | 3 | int:KLK9 | |
| Interaction | SRC interactions | CDC37 ERBB2 THRB EGFR ESR1 ESR2 LRP1 DGKA PRKD1 GRIN2B ADAM12 | 1.62e-04 | 664 | 89 | 11 | int:SRC |
| Interaction | INTS8 interactions | 1.63e-04 | 62 | 89 | 4 | int:INTS8 | |
| Interaction | PIAS1 interactions | 1.68e-04 | 353 | 89 | 8 | int:PIAS1 | |
| Interaction | TLN1 interactions | 1.69e-04 | 264 | 89 | 7 | int:TLN1 | |
| Interaction | RAB25 interactions | 1.73e-04 | 265 | 89 | 7 | int:RAB25 | |
| Interaction | EMD interactions | CDC37 ERBB2 FRAS1 EGFR ESR1 LPL NFX1 TMEM63B NFXL1 EZH2 ITGB1 NOTCH2 | 1.78e-04 | 789 | 89 | 12 | int:EMD |
| Interaction | GPHA2 interactions | 1.78e-04 | 25 | 89 | 3 | int:GPHA2 | |
| Interaction | CCAR1 interactions | 1.81e-04 | 187 | 89 | 6 | int:CCAR1 | |
| Interaction | LIN7C interactions | 1.84e-04 | 119 | 89 | 5 | int:LIN7C | |
| Interaction | EPHA4 interactions | 1.86e-04 | 188 | 89 | 6 | int:EPHA4 | |
| Interaction | MSL3B interactions | 1.91e-04 | 5 | 89 | 2 | int:MSL3B | |
| Interaction | SERPINB4 interactions | 1.92e-04 | 189 | 89 | 6 | int:SERPINB4 | |
| Interaction | RPS26P11 interactions | 1.96e-04 | 65 | 89 | 4 | int:RPS26P11 | |
| Interaction | CSRP1 interactions | 1.96e-04 | 65 | 89 | 4 | int:CSRP1 | |
| Interaction | DDX10 interactions | 1.97e-04 | 190 | 89 | 6 | int:DDX10 | |
| Interaction | RIN2 interactions | 2.01e-04 | 26 | 89 | 3 | int:RIN2 | |
| Interaction | NCOR1 interactions | 2.04e-04 | 363 | 89 | 8 | int:NCOR1 | |
| Interaction | HMG20B interactions | 2.07e-04 | 122 | 89 | 5 | int:HMG20B | |
| Interaction | ZKSCAN1 interactions | 2.08e-04 | 66 | 89 | 4 | int:ZKSCAN1 | |
| Interaction | SEPTIN3 interactions | 2.08e-04 | 66 | 89 | 4 | int:SEPTIN3 | |
| Interaction | SDAD1 interactions | 2.15e-04 | 193 | 89 | 6 | int:SDAD1 | |
| Interaction | SAMD1 interactions | 2.15e-04 | 123 | 89 | 5 | int:SAMD1 | |
| Interaction | ZNF629 interactions | 2.15e-04 | 123 | 89 | 5 | int:ZNF629 | |
| Interaction | L3MBTL3 interactions | 2.15e-04 | 123 | 89 | 5 | int:L3MBTL3 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.28e-08 | 27 | 69 | 5 | 47 | |
| GeneFamily | Nuclear hormone receptors | 1.17e-06 | 49 | 69 | 5 | 71 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 8.57e-05 | 4 | 69 | 2 | 1096 | |
| GeneFamily | Zinc fingers MYM-type | 2.13e-04 | 6 | 69 | 2 | 86 | |
| GeneFamily | Low density lipoprotein receptors | 1.09e-03 | 13 | 69 | 2 | 634 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 4.74e-03 | 27 | 69 | 2 | 1253 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FRAS1 VTN HMCN1 CCN1 CILP OTOGL LAMA2 RSPO4 LTBP3 BMPER SMOC1 OTOG | 2.30e-12 | 191 | 89 | 12 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FRAS1 VTN HMCN1 CCN1 CILP LAMA2 RSPO4 LTBP3 BMPER SMOC1 USH2A OTOG | 3.13e-12 | 196 | 89 | 12 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 FRAS1 VTN HMCN1 CCN1 CILP OTOGL LAMA2 RSPO4 LTBP3 BMPER SMOC1 OTOG | 7.72e-12 | 270 | 89 | 13 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 FRAS1 VTN HMCN1 CCN1 CILP LAMA2 RSPO4 LTBP3 BMPER SMOC1 USH2A OTOG | 9.72e-12 | 275 | 89 | 13 | M5884 |
| Coexpression | NABA_MATRISOME | HSPG2 FRAS1 VTN HMCN1 CCN1 CILP OTOGL ADAM9 LAMA2 ADAM30 RSPO4 ADAM2 LTBP3 BMPER SMOC1 ADAM12 ADAM22 OTOG | 6.70e-09 | 1008 | 89 | 18 | MM17056 |
| Coexpression | NABA_MATRISOME | HSPG2 FRAS1 VTN HMCN1 CCN1 CILP ADAM9 LAMA2 ADAM30 RSPO4 ADAM2 LTBP3 BMPER SMOC1 ADAM12 USH2A ADAM22 OTOG | 8.81e-09 | 1026 | 89 | 18 | M5889 |
| Coexpression | GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN | 4.51e-06 | 194 | 89 | 7 | M4687 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.03e-05 | 40 | 89 | 4 | M5887 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 3.45e-05 | 54 | 89 | 4 | M4737 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C1 | 3.53e-05 | 19 | 89 | 3 | M16026 | |
| Coexpression | GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN | 5.62e-05 | 196 | 89 | 6 | M8171 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 6.29e-05 | 200 | 89 | 6 | M5930 | |
| Coexpression | GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP | 6.29e-05 | 200 | 89 | 6 | M8527 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | CCN1 ADAM9 LRP1 LAMA2 DGKA EBF1 ADAM12 ITGB1 NOTCH2 NOTCH3 RASGRP2 | 7.92e-05 | 795 | 89 | 11 | M39050 |
| Coexpression | ACEVEDO_LIVER_CANCER_DN | 9.22e-05 | 540 | 89 | 9 | M7577 | |
| Coexpression | HALLMARK_COAGULATION | 1.10e-04 | 138 | 89 | 5 | M5946 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 1.12e-04 | 432 | 89 | 8 | MM419 | |
| Coexpression | LOPES_METHYLATED_IN_COLON_CANCER_DN | 1.17e-04 | 28 | 89 | 3 | M12717 | |
| Coexpression | DESCARTES_FETAL_LIVER_VASCULAR_ENDOTHELIAL_CELLS | 1.34e-04 | 144 | 89 | 5 | M40230 | |
| Coexpression | GSE45365_NK_CELL_VS_BCELL_DN | 1.38e-04 | 145 | 89 | 5 | M10023 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | HSPG2 VTN HMCN1 CCN1 EGFR EBF3 LPL LRP1 LAMA2 LTBP3 EBF1 ADAM12 NOTCH3 | 6.23e-08 | 466 | 88 | 13 | GSM777050_500 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.33e-05 | 437 | 88 | 10 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.88e-05 | 455 | 88 | 10 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 2.75e-05 | 85 | 88 | 5 | GSM777067_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.93e-05 | 151 | 88 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_500 | 4.99e-05 | 409 | 88 | 9 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 5.20e-05 | 97 | 88 | 5 | GSM777046_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 9.51e-05 | 445 | 88 | 9 | GSM777043_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.08e-04 | 113 | 88 | 5 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k1 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.09e-04 | 453 | 88 | 9 | GSM777067_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.16e-04 | 356 | 88 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 1.32e-04 | 188 | 88 | 6 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ERBB2 HMCN1 CCN1 LPL LRP1 NFXL1 KIF4A PRKD1 BMPER SMOC1 ZMYM3 NOTCH2 | 1.52e-04 | 827 | 88 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | EBF2 HMCN1 CCN1 EGFR EBF3 ADAM9 LRP1 MYRIP EBF1 BMPER ADAM12 ITGB1 MT1HL1 | 1.83e-04 | 975 | 88 | 13 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#4_top-relative-expression-ranked_200 | 1.83e-04 | 68 | 88 | 4 | gudmap_developingKidney_e13.5_podocyte cells_200_k4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.95e-04 | 288 | 88 | 7 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 2.40e-04 | 298 | 88 | 7 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#1_top-relative-expression-ranked_500 | 3.13e-04 | 142 | 88 | 5 | gudmap_developingKidney_e13.5_podocyte cells_500_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | 3.22e-04 | 414 | 88 | 8 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_top-relative-expression-ranked_500 | 3.22e-04 | 414 | 88 | 8 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | HMCN1 CCN1 EGFR LPL LRP1 LAMA2 KIF4A SMOC1 ADAM12 ZMYM3 NOTCH2 | 3.27e-04 | 768 | 88 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | THRB CCN1 EGFR ADAM9 LRP2 EBF1 HNF4A ITGB1 ADAM22 NOTCH2 NOTCH3 RASGRP2 | 3.48e-04 | 905 | 88 | 12 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 3.55e-04 | 146 | 88 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 3.65e-04 | 778 | 88 | 11 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 3.76e-04 | 82 | 88 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | EBF2 HMCN1 EGFR EBF3 LRRTM4 PRKD1 LTBP3 EBF1 BMPER ZNF229 ADAM22 | 4.20e-04 | 791 | 88 | 11 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | HMCN1 CCN1 EGFR LRP1 LAMA2 KIF4A PRKD1 SMOC1 ADAM12 ZMYM3 NOTCH2 | 4.29e-04 | 793 | 88 | 11 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_top-relative-expression-ranked_1000 | TRAF7 HSPG2 STAB2 HMCN1 CCN1 EBF3 EBF1 ADAM12 RASGRP2 STAB1 MSL2 | 4.38e-04 | 795 | 88 | 11 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_200 | 4.93e-04 | 88 | 88 | 4 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k4_200 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.88e-04 | 163 | 88 | 5 | gudmap_kidney_P0_JuxtaGlom_Ren1_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.07e-04 | 250 | 88 | 6 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#1_top-relative-expression-ranked_500 | 6.54e-04 | 41 | 88 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-09 | 177 | 89 | 8 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-09 | 177 | 89 | 8 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-09 | 184 | 89 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-09 | 184 | 89 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-09 | 184 | 89 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-09 | 188 | 89 | 8 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.42e-09 | 194 | 89 | 8 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.11e-09 | 197 | 89 | 8 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.11e-09 | 197 | 89 | 8 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.11e-09 | 197 | 89 | 8 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-08 | 160 | 89 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-08 | 160 | 89 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-08 | 170 | 89 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-08 | 175 | 89 | 7 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.63e-08 | 180 | 89 | 7 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.63e-08 | 180 | 89 | 7 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.63e-08 | 180 | 89 | 7 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.63e-08 | 180 | 89 | 7 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.54e-08 | 186 | 89 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-08 | 187 | 89 | 7 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-08 | 187 | 89 | 7 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-08 | 187 | 89 | 7 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-07 | 188 | 89 | 7 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-07 | 190 | 89 | 7 | 7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-07 | 190 | 89 | 7 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-07 | 191 | 89 | 7 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 192 | 89 | 7 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 192 | 89 | 7 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 192 | 89 | 7 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-07 | 192 | 89 | 7 | 011634a24b0c61d9b463fe755502edbc5cd70b7a | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-07 | 193 | 89 | 7 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-07 | 193 | 89 | 7 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.32e-07 | 195 | 89 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-07 | 196 | 89 | 7 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-07 | 196 | 89 | 7 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.36e-07 | 196 | 89 | 7 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-07 | 197 | 89 | 7 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-07 | 199 | 89 | 7 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.01e-07 | 162 | 89 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.24e-06 | 171 | 89 | 6 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-06 | 172 | 89 | 6 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.32e-06 | 173 | 89 | 6 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-06 | 175 | 89 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 176 | 89 | 6 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-06 | 179 | 89 | 6 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.72e-06 | 181 | 89 | 6 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-06 | 181 | 89 | 6 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 184 | 89 | 6 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.95e-06 | 185 | 89 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.01e-06 | 186 | 89 | 6 | db9b67066fc003c7995ec205d15176bf40c97add | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.08e-06 | 187 | 89 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-06 | 187 | 89 | 6 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.08e-06 | 187 | 89 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.14e-06 | 188 | 89 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.14e-06 | 188 | 89 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-06 | 189 | 89 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 2.21e-06 | 189 | 89 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-06 | 189 | 89 | 6 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-06 | 190 | 89 | 6 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-06 | 190 | 89 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-06 | 190 | 89 | 6 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-06 | 190 | 89 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.28e-06 | 190 | 89 | 6 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 190 | 89 | 6 | ad0f5605db6b694445ec9bd5dc8d2d834358c0f9 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-06 | 190 | 89 | 6 | 7fec459cd2ad12c2923a03d098289337c0a4c1d3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-06 | 190 | 89 | 6 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 191 | 89 | 6 | 83d1915835df6f2eb23f87986d695e71398edb9d | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 191 | 89 | 6 | a57cf0519d749febc0b69fe0b098b7ba53d63258 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 191 | 89 | 6 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 191 | 89 | 6 | 19c67a812b8ce97472d316acd15aeefe8736000d | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 191 | 89 | 6 | 1efb47743b6834b64cb0f61721ddbe875b1a66ca | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.35e-06 | 191 | 89 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 192 | 89 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 192 | 89 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.42e-06 | 192 | 89 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 192 | 89 | 6 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.42e-06 | 192 | 89 | 6 | 063e119c4b58957643908f667e6cfd6f7517fd03 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.42e-06 | 192 | 89 | 6 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-06 | 193 | 89 | 6 | 3ea6b103e35bbb276e95301999618558fa3e38b1 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.49e-06 | 193 | 89 | 6 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 193 | 89 | 6 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.49e-06 | 193 | 89 | 6 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.49e-06 | 193 | 89 | 6 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.49e-06 | 193 | 89 | 6 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 193 | 89 | 6 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.49e-06 | 193 | 89 | 6 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-06 | 194 | 89 | 6 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 194 | 89 | 6 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-06 | 194 | 89 | 6 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 195 | 89 | 6 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-06 | 195 | 89 | 6 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | background-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.64e-06 | 195 | 89 | 6 | c7d60dabfc7cb310e002cab10003dadfcc34fe33 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-06 | 195 | 89 | 6 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-06 | 195 | 89 | 6 | fc43cd295f2cc3f6e9442232e028944f011c82cc | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 195 | 89 | 6 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-06 | 195 | 89 | 6 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.64e-06 | 195 | 89 | 6 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 195 | 89 | 6 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 196 | 89 | 6 | 65f2f51e17f1869f3468813127b96d3048d8ad41 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 196 | 89 | 6 | e4ed897900a6472738bc6be2fb4817192727225d | |
| Drug | 2,6-diisopropylnaphthalene | 2.30e-07 | 4 | 89 | 3 | ctd:C018520 | |
| Drug | lauric acid methyl ester | 5.74e-07 | 5 | 89 | 3 | ctd:C089549 | |
| Drug | 2-tert-butylphenol | 5.74e-07 | 5 | 89 | 3 | ctd:C035406 | |
| Drug | exemestane | 6.97e-07 | 43 | 89 | 5 | CID000060198 | |
| Drug | Epirubicin | 1.10e-06 | 47 | 89 | 5 | ctd:D015251 | |
| Drug | Teniposide | 1.24e-06 | 21 | 89 | 4 | ctd:D013713 | |
| Drug | AC1L1CT9 | 1.82e-06 | 23 | 89 | 4 | CID000002054 | |
| Drug | secoisolariciresinol diglucoside | 2.00e-06 | 7 | 89 | 3 | ctd:C090142 | |
| Drug | 1H,1H,2H,2H-perfluorooctan-1-ol | 2.00e-06 | 7 | 89 | 3 | CID000069537 | |
| Drug | ethyl myristate | 2.00e-06 | 7 | 89 | 3 | ctd:C032396 | |
| Drug | 8:2 FTOH | 2.00e-06 | 7 | 89 | 3 | CID000069619 | |
| Drug | 1H,1H,2H,2H-perfluorooctan-1-ol | 3.19e-06 | 8 | 89 | 3 | ctd:C508406 | |
| Drug | tetrachloroisophthalonitrile | 3.19e-06 | 8 | 89 | 3 | ctd:C005806 | |
| Drug | AC1L1K7W | 9.25e-06 | 34 | 89 | 4 | CID000005377 | |
| Drug | compound 56 | 9.31e-06 | 11 | 89 | 3 | CID000002857 | |
| Drug | ICI 164384 | 9.31e-06 | 11 | 89 | 3 | ctd:C051781 | |
| Drug | prochloraz | 1.03e-05 | 268 | 89 | 8 | ctd:C045362 | |
| Drug | AC1L9M2J | 1.21e-05 | 76 | 89 | 5 | CID000448538 | |
| Drug | SureCN2313095 | 1.21e-05 | 76 | 89 | 5 | CID011840973 | |
| Drug | dronedarone | 1.24e-05 | 12 | 89 | 3 | ctd:C118667 | |
| Drug | anastrozole | 1.31e-05 | 37 | 89 | 4 | CID000002187 | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; PC3; HT_HG-U133A | 1.32e-05 | 199 | 89 | 7 | 6618_UP | |
| Drug | 1pxm | 1.37e-05 | 78 | 89 | 5 | CID000447959 | |
| Drug | 5-octylphenol | 1.51e-05 | 2 | 89 | 2 | ctd:C113977 | |
| Drug | tetradifon | 1.51e-05 | 2 | 89 | 2 | ctd:C005807 | |
| Drug | etocrylene | 1.51e-05 | 2 | 89 | 2 | CID000243274 | |
| Drug | N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide | 1.51e-05 | 2 | 89 | 2 | ctd:C570404 | |
| Drug | Raloxifene | 1.51e-05 | 2 | 89 | 2 | DB00481 | |
| Drug | Brn 0187733 | 1.51e-05 | 2 | 89 | 2 | CID000160446 | |
| Drug | PHTPP | 1.51e-05 | 2 | 89 | 2 | CID011201035 | |
| Drug | butolame | 1.51e-05 | 2 | 89 | 2 | CID000197608 | |
| Drug | LY 326315 | 1.51e-05 | 2 | 89 | 2 | CID009803972 | |
| Drug | JK 1624F2-1 | 1.51e-05 | 2 | 89 | 2 | ctd:C113642 | |
| Drug | octocrylene | 1.51e-05 | 2 | 89 | 2 | ctd:C088673 | |
| Drug | O-desmethylangolensin | 1.51e-05 | 2 | 89 | 2 | ctd:C050052 | |
| Drug | CHEMBL397775 | 1.51e-05 | 2 | 89 | 2 | CID010214678 | |
| Drug | Cyclohexanone, 3b | 1.51e-05 | 2 | 89 | 2 | CID011370317 | |
| Drug | Lapatinib | 1.51e-05 | 2 | 89 | 2 | DB01259 | |
| Drug | CHEMBL234633 | 1.51e-05 | 2 | 89 | 2 | CID010192968 | |
| Drug | SureCN14514707 | 1.51e-05 | 2 | 89 | 2 | CID010192967 | |
| Drug | (4R)-6-(ethoxymethyl)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol | 1.51e-05 | 2 | 89 | 2 | CID011175195 | |
| Drug | (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL | 1.51e-05 | 2 | 89 | 2 | DB08020 | |
| Drug | ethyl cinnamate | 1.51e-05 | 2 | 89 | 2 | ctd:C451418 | |
| Drug | (4R)-4-(4-hydroxyphenyl)-6-methylol-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol | 1.51e-05 | 2 | 89 | 2 | CID011174414 | |
| Drug | phytoene | 1.51e-05 | 2 | 89 | 2 | ctd:C100185 | |
| Drug | CHEMBL48352 | 1.51e-05 | 2 | 89 | 2 | CID011522286 | |
| Drug | bromophos | 1.51e-05 | 2 | 89 | 2 | ctd:C100092 | |
| Drug | SureCN14514705 | 1.51e-05 | 2 | 89 | 2 | CID010125414 | |
| Drug | 3,4-dihydroxybenzaldoxime | 1.51e-05 | 2 | 89 | 2 | ctd:C053286 | |
| Drug | Tamoxifen | 1.51e-05 | 2 | 89 | 2 | DB00675 | |
| Drug | SureCN14514737 | 1.51e-05 | 2 | 89 | 2 | CID010149292 | |
| Drug | di-(5-methylhexyl)phthalate | 1.51e-05 | 2 | 89 | 2 | ctd:C042791 | |
| Drug | phytofluene | 1.51e-05 | 2 | 89 | 2 | ctd:C003140 | |
| Drug | 1x7e | 1.51e-05 | 2 | 89 | 2 | CID000656953 | |
| Drug | salicylaldoxime | 1.51e-05 | 2 | 89 | 2 | ctd:C005704 | |
| Drug | Pyrazolo[1,5-a]pyrimidine, 12d | 1.51e-05 | 2 | 89 | 2 | CID016103245 | |
| Drug | Pyrazolo[1,5-a]pyrimidine, 12c | 1.51e-05 | 2 | 89 | 2 | CID016103238 | |
| Drug | SureCN3587271 | 1.51e-05 | 2 | 89 | 2 | CID011208678 | |
| Drug | CNP-amino | 1.51e-05 | 2 | 89 | 2 | CID000033473 | |
| Drug | ERB 041 | 1.51e-05 | 2 | 89 | 2 | ctd:C478102 | |
| Drug | (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL | 1.51e-05 | 2 | 89 | 2 | DB07933 | |
| Drug | 4-(4-hydroxyphenyl)-6-methyl-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol | 1.51e-05 | 2 | 89 | 2 | CID010125512 | |
| Drug | 2-phenylbenzofuran | 1.51e-05 | 2 | 89 | 2 | CID003517936 | |
| Drug | steroid C | 1.51e-05 | 2 | 89 | 2 | CID000454473 | |
| Drug | 2z4b | 1.51e-05 | 2 | 89 | 2 | CID011197931 | |
| Drug | dehydroestrone | 1.51e-05 | 2 | 89 | 2 | CID000102225 | |
| Drug | (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL | 1.51e-05 | 2 | 89 | 2 | DB07638 | |
| Drug | prolame | 1.51e-05 | 2 | 89 | 2 | CID000127441 | |
| Drug | benzohydrol | 1.51e-05 | 2 | 89 | 2 | ctd:C020225 | |
| Drug | parthenocissin A | 1.51e-05 | 2 | 89 | 2 | ctd:C549189 | |
| Drug | CHEBI:428946 | 1.51e-05 | 2 | 89 | 2 | CID011688293 | |
| Drug | F ppt | 1.51e-05 | 2 | 89 | 2 | CID003035869 | |
| Drug | SureCN3118249 | 1.51e-05 | 2 | 89 | 2 | CID011519653 | |
| Drug | SureCN4017709 | 1.51e-05 | 2 | 89 | 2 | CID011256602 | |
| Drug | CHEBI:428959 | 1.51e-05 | 2 | 89 | 2 | CID011638242 | |
| Drug | DNC005795 | 1.51e-05 | 2 | 89 | 2 | CID011638264 | |
| Drug | tetrahydrodaidzein | 1.51e-05 | 2 | 89 | 2 | ctd:C433164 | |
| Drug | tri-(2-ethylhexyl)trimellitate | 1.51e-05 | 2 | 89 | 2 | ctd:C036101 | |
| Drug | 2-chloro-4-phenylphenol | 1.51e-05 | 2 | 89 | 2 | ctd:C012257 | |
| Drug | 2,2,4-trimethyl-1,3-pentanediol diisobutyrate | 1.51e-05 | 2 | 89 | 2 | ctd:C001508 | |
| Drug | 2-(3-chloro-4-hydroxyphenyl)-2-(4-hydroxyphenyl)propane | 1.51e-05 | 2 | 89 | 2 | ctd:C497826 | |
| Drug | 2,2-bis(3-chloro-4-hydroxyphenyl)propane | 1.51e-05 | 2 | 89 | 2 | ctd:C497827 | |
| Drug | 1-ethyl-2-(4-hydroxyphenyl)-3H-inden-5-ol | 1.51e-05 | 2 | 89 | 2 | CID011615788 | |
| Drug | SureCN3593776 | 1.51e-05 | 2 | 89 | 2 | CID009948127 | |
| Drug | SureCN14047367 | 1.51e-05 | 2 | 89 | 2 | CID010171723 | |
| Drug | Y134 compound | 1.51e-05 | 2 | 89 | 2 | ctd:C518540 | |
| Drug | TS 108 | 1.51e-05 | 2 | 89 | 2 | ctd:C482068 | |
| Drug | Estriol | 1.51e-05 | 2 | 89 | 2 | DB04573 | |
| Drug | Estropipate | 1.51e-05 | 2 | 89 | 2 | DB04574 | |
| Drug | CHEBI:428952 | 1.51e-05 | 2 | 89 | 2 | CID011674420 | |
| Drug | 6-(4-hydroxyphenyl)-6,6a,7,8,9,10,11,11a-octahydrocyclohepta[c]chromen-2-ol | 1.51e-05 | 2 | 89 | 2 | CID010215026 | |
| Drug | 4-(2-chloro-4-(2-piperidin-1-ylethoxy)phenyl)-5-(2,6-dichloro-4-hydroxyphenyl)-2-imidazoline | 1.51e-05 | 2 | 89 | 2 | ctd:C496952 | |
| Drug | cycloprothrin | 1.51e-05 | 2 | 89 | 2 | ctd:C528277 | |
| Drug | indenestrol | 1.51e-05 | 2 | 89 | 2 | ctd:C047437 | |
| Drug | [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE | 1.51e-05 | 2 | 89 | 2 | DB06927 | |
| Drug | LY2066948 | 1.51e-05 | 2 | 89 | 2 | CID005327043 | |
| Drug | SERBA-2 | 1.51e-05 | 2 | 89 | 2 | CID009925763 | |
| Drug | SureCN1360427 | 1.51e-05 | 2 | 89 | 2 | CID011720174 | |
| Drug | 16 alpha-iodoestradiol | 1.51e-05 | 2 | 89 | 2 | ctd:C024871 | |
| Drug | 1H,1H,2H,2H-perfluorodecanol | 1.61e-05 | 13 | 89 | 3 | ctd:C033729 | |
| Disease | Prostatic Neoplasms | KMT2C ERBB2 STAB2 EGFR ADAM9 ESR1 ESR2 LPL MBD1 LRP2 EZH2 ZMYM3 | 2.63e-07 | 616 | 87 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | KMT2C ERBB2 STAB2 EGFR ADAM9 ESR1 ESR2 LPL MBD1 LRP2 EZH2 ZMYM3 | 2.63e-07 | 616 | 87 | 12 | C0376358 |
| Disease | Liver carcinoma | 2.99e-07 | 507 | 87 | 11 | C2239176 | |
| Disease | Carcinoma, Granular Cell | 1.26e-06 | 116 | 87 | 6 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.26e-06 | 116 | 87 | 6 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.26e-06 | 116 | 87 | 6 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.26e-06 | 116 | 87 | 6 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.26e-06 | 116 | 87 | 6 | C0205641 | |
| Disease | Adenocarcinoma | 1.26e-06 | 116 | 87 | 6 | C0001418 | |
| Disease | osteoarthritis (is_implicated_in) | 1.37e-06 | 28 | 87 | 4 | DOID:8398 (is_implicated_in) | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.38e-06 | 32 | 87 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | Bladder Neoplasm | 3.77e-06 | 140 | 87 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.93e-06 | 141 | 87 | 6 | C0005684 | |
| Disease | Migraine Disorders | 6.93e-06 | 13 | 87 | 3 | C0149931 | |
| Disease | prostate carcinoma in situ (implicated_via_orthology) | 8.59e-06 | 2 | 87 | 2 | DOID:8634 (implicated_via_orthology) | |
| Disease | prostate cancer (is_implicated_in) | 2.56e-05 | 117 | 87 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | peritonitis (implicated_via_orthology) | 2.57e-05 | 3 | 87 | 2 | DOID:8283 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 4.31e-05 | 215 | 87 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (is_implicated_in) | 4.57e-05 | 132 | 87 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | Intrahepatic Cholangiocarcinoma | 4.79e-05 | 24 | 87 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 4.79e-05 | 24 | 87 | 3 | C3805278 | |
| Disease | Fanconi syndrome (implicated_via_orthology) | 5.14e-05 | 4 | 87 | 2 | DOID:1062 (implicated_via_orthology) | |
| Disease | Cerebral Astrocytoma | 5.43e-05 | 25 | 87 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 5.43e-05 | 25 | 87 | 3 | C0750936 | |
| Disease | Astrocytoma | 5.43e-05 | 25 | 87 | 3 | C0004114 | |
| Disease | breast carcinoma (is_implicated_in) | 5.43e-05 | 25 | 87 | 3 | DOID:3459 (is_implicated_in) | |
| Disease | Grade I Astrocytoma | 5.43e-05 | 25 | 87 | 3 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 5.43e-05 | 25 | 87 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 5.43e-05 | 25 | 87 | 3 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 5.43e-05 | 25 | 87 | 3 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 5.43e-05 | 25 | 87 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 5.43e-05 | 25 | 87 | 3 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 5.43e-05 | 25 | 87 | 3 | C0338070 | |
| Disease | Cholangiocarcinoma | 6.13e-05 | 26 | 87 | 3 | C0206698 | |
| Disease | Gemistocytic astrocytoma | 6.13e-05 | 26 | 87 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 6.13e-05 | 26 | 87 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 6.13e-05 | 26 | 87 | 3 | C0334582 | |
| Disease | Endometrial Carcinoma | 6.22e-05 | 72 | 87 | 4 | C0476089 | |
| Disease | Animal Mammary Neoplasms | 6.47e-05 | 142 | 87 | 5 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 6.47e-05 | 142 | 87 | 5 | C1257925 | |
| Disease | Anaplastic astrocytoma | 6.88e-05 | 27 | 87 | 3 | C0334579 | |
| Disease | catenin alpha-2 measurement | 8.54e-05 | 5 | 87 | 2 | EFO_0802374 | |
| Disease | low-density lipoprotein receptor-related protein 1, soluble measurement | 8.54e-05 | 5 | 87 | 2 | EFO_0801772 | |
| Disease | Cetuximab response | 8.54e-05 | 5 | 87 | 2 | cv:CN077967 | |
| Disease | Panitumumab response | 8.54e-05 | 5 | 87 | 2 | cv:CN077999 | |
| Disease | Mammary Neoplasms, Experimental | 9.79e-05 | 155 | 87 | 5 | C0024668 | |
| Disease | Craniofacial Abnormalities | 1.01e-04 | 156 | 87 | 5 | C0376634 | |
| Disease | Opioid abuse | 1.28e-04 | 6 | 87 | 2 | C0029095 | |
| Disease | Opiate Abuse | 1.28e-04 | 6 | 87 | 2 | C4551628 | |
| Disease | familial combined hyperlipidemia (is_implicated_in) | 1.28e-04 | 6 | 87 | 2 | DOID:13809 (is_implicated_in) | |
| Disease | Narcotic Dependence | 1.28e-04 | 6 | 87 | 2 | C1527402 | |
| Disease | Opiate Addiction | 1.28e-04 | 6 | 87 | 2 | C0524662 | |
| Disease | Narcotic Abuse | 1.28e-04 | 6 | 87 | 2 | C0524661 | |
| Disease | Opioid-Related Disorders | 1.28e-04 | 6 | 87 | 2 | C0027412 | |
| Disease | Lung Neoplasms | 1.36e-04 | 265 | 87 | 6 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.39e-04 | 266 | 87 | 6 | C0242379 | |
| Disease | Solid Neoplasm | 1.79e-04 | 7 | 87 | 2 | C0280100 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 1.79e-04 | 7 | 87 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 1.79e-04 | 7 | 87 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 1.83e-04 | 95 | 87 | 4 | C0279626 | |
| Disease | Neoplasm Recurrence, Local | 2.10e-04 | 39 | 87 | 3 | C0027643 | |
| Disease | CREB-binding protein measurement | 2.38e-04 | 8 | 87 | 2 | EFO_0801502 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.43e-04 | 41 | 87 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.43e-04 | 41 | 87 | 3 | C0858252 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.85e-04 | 195 | 87 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | urinary bladder cancer (is_marker_for) | 2.89e-04 | 107 | 87 | 4 | DOID:11054 (is_marker_for) | |
| Disease | Acute Confusional Migraine | 3.05e-04 | 9 | 87 | 2 | C0521664 | |
| Disease | Status Migrainosus | 3.05e-04 | 9 | 87 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 3.05e-04 | 9 | 87 | 2 | C0270858 | |
| Disease | Sick Headaches | 3.05e-04 | 9 | 87 | 2 | C0700438 | |
| Disease | Cervical Migraine Syndrome | 3.05e-04 | 9 | 87 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 3.05e-04 | 9 | 87 | 2 | C0018984 | |
| Disease | Malignant neoplasm of breast | RIF1 ERBB2 EGFR OTOGL ESR1 ESR2 LAMA2 EZH2 ADAM12 NOTCH2 NOTCH3 | 3.15e-04 | 1074 | 87 | 11 | C0006142 |
| Disease | Bone Diseases | 3.81e-04 | 10 | 87 | 2 | C0005940 | |
| Disease | Head and Neck Carcinoma | 3.81e-04 | 10 | 87 | 2 | C3887461 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 3.81e-04 | 10 | 87 | 2 | EFO_0008321 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 4.14e-04 | 49 | 87 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Prostatic Intraepithelial Neoplasias | 4.65e-04 | 11 | 87 | 2 | C0282612 | |
| Disease | gallbladder neoplasm | 4.65e-04 | 11 | 87 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 4.65e-04 | 11 | 87 | 2 | C0153452 | |
| Disease | Squamous cell carcinoma | 5.05e-04 | 124 | 87 | 4 | C0007137 | |
| Disease | tuberculin skin test reactivity measurement, decreased susceptibility to bacterial infection | 5.56e-04 | 12 | 87 | 2 | EFO_0008307, EFO_0008322 | |
| Disease | Hirschsprung's disease (implicated_via_orthology) | 5.56e-04 | 12 | 87 | 2 | DOID:10487 (implicated_via_orthology) | |
| Disease | Papilloma | 5.56e-04 | 12 | 87 | 2 | C0030354 | |
| Disease | fructose measurement, glucose measurement, galactose measurement | 5.56e-04 | 12 | 87 | 2 | EFO_0004468, EFO_0010477, EFO_0010481 | |
| Disease | Papillomatosis | 5.56e-04 | 12 | 87 | 2 | C0205875 | |
| Disease | Papilloma, Squamous Cell | 5.56e-04 | 12 | 87 | 2 | C0205874 | |
| Disease | phospholipids in medium HDL measurement | 5.81e-04 | 55 | 87 | 3 | EFO_0022295 | |
| Disease | total lipids in medium HDL measurement | 6.79e-04 | 58 | 87 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 6.79e-04 | 58 | 87 | 3 | EFO_0022267 | |
| Disease | Endometrial Neoplasms | 6.79e-04 | 58 | 87 | 3 | C0014170 | |
| Disease | Metabolic Bone Disorder | 7.64e-04 | 14 | 87 | 2 | C0005944 | |
| Disease | Neoplasm of lung | 7.64e-04 | 14 | 87 | 2 | cv:C0024121 | |
| Disease | median neuropathy (biomarker_via_orthology) | 7.64e-04 | 14 | 87 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | Lung cancer | 7.64e-04 | 14 | 87 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 7.64e-04 | 14 | 87 | 2 | 211980 | |
| Disease | phospholipids in HDL measurement | 7.87e-04 | 61 | 87 | 3 | EFO_0022293 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 8.65e-04 | 63 | 87 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | total lipids in HDL measurement | 8.65e-04 | 63 | 87 | 3 | EFO_0022307 | |
| Disease | Lymphoma, Follicular, Grade 2 | 8.80e-04 | 15 | 87 | 2 | C1956132 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGTQRCEKCSKPCAR | 326 | P04626 | |
| CGQDFQCKETGRCLK | 96 | P07357 | |
| CTTDKCNDRGVCNNK | 616 | Q99965 | |
| VRDGCGCCKVCAKQL | 46 | O00622 | |
| RFCDQCKQDKACRFL | 116 | Q6NXE6 | |
| ICFGGRCKTRDRQCK | 541 | Q9P0K1 | |
| SRCCEKKSCGNRNET | 161 | Q9HAK2 | |
| TKCADGKICLNRQCQ | 636 | O43184 | |
| CCDPENKQRELCKNR | 1406 | Q96F81 | |
| ACRCKNNVVGRLCNE | 891 | P98160 | |
| RCLKANAKSCGECIQ | 26 | P05556 | |
| RCQSSCGQVKCRKGE | 1341 | Q04721 | |
| RQGLQCKDCRFNCHK | 296 | Q15139 | |
| RCAKCLCRNGVAQCF | 176 | Q86XX4 | |
| KCKNCRICIECGTRS | 431 | Q8NEZ4 | |
| CAKCAQGCIRKGASE | 41 | P0DM35 | |
| CTIDKNRRKSCQACR | 191 | Q92731 | |
| QRACPKNCRCDGKIV | 31 | Q86VH4 | |
| QKCVCGKKVAERSCA | 341 | Q6ZNB6 | |
| ALKCTACNENGLQRC | 271 | A8MXD5 | |
| ACGVNCHKQCKDRLS | 531 | Q7LDG7 | |
| CKDKKEFLCRNQRCL | 3741 | Q07954 | |
| VNKCSRCLEGACVVN | 4341 | Q07954 | |
| DILKNKRCRNKCGCL | 1116 | Q2LD37 | |
| QCVVDKDKRNQCRYC | 101 | P41235 | |
| NRRQNRKCGACAACL | 331 | Q9UIS9 | |
| RFPGCRCKAQCNTKQ | 556 | Q15910 | |
| QCTIDKNRRKSCQAC | 226 | P03372 | |
| AFEKGLCLSCRKNRC | 296 | P06858 | |
| ACQAKRGDQRCDREC | 1391 | Q9UM47 | |
| GCESGRCDRCQKKIR | 276 | P23743 | |
| KRLCGRHKCNEICCV | 691 | Q12986 | |
| ACKAKVELQCECGRR | 881 | Q12986 | |
| LCAACLRKCQNARDN | 206 | Q8N456 | |
| QCECRANVQGQRCDK | 936 | P24043 | |
| GCNKGKERTCAENIC | 3961 | P98164 | |
| GEAVKDTCKNLRACC | 41 | Q96PH6 | |
| NRKACLDCICRGCQN | 486 | Q9HCI7 | |
| CLNNFRKRLKCFRCG | 191 | P52756 | |
| RKCMDVNECRQNVCR | 5226 | Q96RW7 | |
| CRNVSRGRECVDKCN | 526 | P00533 | |
| SCGEGRVCFKKNCVN | 611 | Q9UKF2 | |
| EKCNTRGVCNNRKNC | 636 | Q9UKF2 | |
| GRAEGRQARKSACKC | 181 | Q8N8I6 | |
| CALAIKQRGACCEQC | 91 | Q8N8U9 | |
| ICACVKGRTECRNKQ | 321 | Q8N8U9 | |
| SAANAAQRGKCCCCR | 46 | Q8WXQ3 | |
| DRGCRECKRKVAECQ | 51 | Q16543 | |
| LKDFNVCKCQGCTCR | 376 | Q5T3F8 | |
| TKCGAGKICRNFQCV | 621 | Q13443 | |
| CSRCCDKKSCGNRNE | 161 | Q9UH73 | |
| GKNCVIGRRCVLKDC | 111 | Q9BTE1 | |
| CKRTCLKGQCRDSCQ | 71 | Q9NS15 | |
| CCDPTKCRNRQQGKD | 1111 | O95239 | |
| NKQCGCRKQKSDCGV | 1096 | Q2VIQ3 | |
| CSRCCDKKSCGNRNE | 161 | Q9H4W6 | |
| RCIKMRLRCNGDNDC | 111 | P02748 | |
| CFSRCDLRVNKCGAQ | 326 | Q0P6D2 | |
| GCCKICKREERICQK | 2256 | Q3ZCN5 | |
| VDCRKVCGLNVSDRC | 51 | Q6J4K2 | |
| CKCCREVGLQRRSVQ | 2886 | Q6ZRI0 | |
| HNKGCNCRRSGCLKN | 366 | Q9Y4I5 | |
| SCQAVVKKGCPRCAR | 1031 | Q9Y4G2 | |
| KCKANVIGLRCDHCN | 716 | O75445 | |
| CKRFKEGTCQRGDQC | 606 | Q9NXH9 | |
| REVEKRCQTCKANLC | 141 | Q9H8W5 | |
| RGQEVNRCKKCGATC | 81 | Q2I0M5 | |
| VRRSKGCDCCGEKSQ | 1726 | Q5UIP0 | |
| NKKKCCCNGPRACRE | 366 | Q14943 | |
| CQQCRLRKCKEAGMR | 141 | P55055 | |
| SCCGAKRKAKQSRRC | 201 | Q9Y2M2 | |
| RCRDAVQNCCGISKT | 446 | O75339 | |
| AGMRCCGCRERNINK | 111 | B7Z368 | |
| RCKDAGQSKCRLERA | 86 | Q9H4F8 | |
| KCEECGKVFNRCSNL | 126 | Q5SXM1 | |
| CGNDICFRKQNAKCD | 566 | Q7RTY8 | |
| CFRKQNAKCDGTVDC | 571 | Q7RTY8 | |
| ATCQQREGKKICICN | 46 | Q6UWL2 | |
| VTRNQCQECRFKKCI | 156 | P10828 | |
| QVANFCRRVCAKLEC | 621 | Q5VUG0 | |
| CEVCGFQCRQRASLK | 526 | Q8N554 | |
| CRRCALKSEKCPVDN | 151 | Q6Q0C0 | |
| KCGKACTRRCNLIQH | 261 | Q13398 | |
| GCRRKCRKQVVQKAC | 86 | Q9NY15 | |
| CKQDNGGCAKVARCS | 2086 | Q8WWQ8 | |
| CERNIQCVTCGKAFK | 486 | Q9UFB7 | |
| GCNKCRKDCIKNSVL | 241 | Q9UJW7 | |
| ARCDCCKSQGTLKER | 766 | Q9UBW7 | |
| SANKNIICRNCDKRG | 236 | Q8N3Z6 | |
| IRCTNCARCVPKDKA | 21 | P62854 | |
| ECDKCQRRQKNRAFC | 41 | Q9Y3S2 | |
| GRCTEGFNVDKKCQC | 26 | P04004 | |
| RANKGLKTNCCDQCG | 441 | Q14202 | |
| RLFSQRKPCKCNECE | 101 | Q9UJN7 | |
| NTKRQCGDCKFNVCK | 76 | Q8NFW9 | |
| RQACIRCEACKKAGN | 1236 | Q13224 |